UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

___________________

SCHEDULE 14A

___________________

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934

Filed by the Registrant

 

Filed by a Party other than the Registrant

 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, For Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Pursuant to §240.14a-12

QUANTUM COMPUTING INC.

(Name of Registrant as Specified in its Charter)


(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)

Title of each class of securities to which transaction applies:

(2)

Aggregate number of securities to which transaction applies:

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4)

Proposed maximum aggregate value of transaction:

(5)

Total fee paid:

Fee paid previously with preliminary materials.

 

Check box if any part of the fee is offset as providedFee computed on table in exhibit required by Item 25(b) per Exchange Act RuleRules 14a- 6(i)(1) and 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)

Amount previously paid:

(2)

Form, Schedule or Registration Statement No.:

(3)

Filing Party:

(4)

Date Filed:

.

 

Table of Contents

QUANTUM COMPUTING INC.

September 28, 202127, 2023

Dear Fellow Quantum Computing Stockholders:

We invite you to attend the 20212023 Annual Meeting of Stockholders of Quantum Computing Inc. to be held at the Quantum Computing corporate offices located at 215 Depot Court SE, Suite 215, Leesburg, VA 20175 on Tuesday, November 12, 2021, at 10:00 a.m. local time.7, 2023.

The Notice of the Annual Meeting and Proxy Statementproxy statement accompanying this letter provide information concerning matters to be considered and acted upon at the meeting. Immediately following the meeting, a report on our operations will be presented, including a question-and-answer and discussion period. Our 20202022 results are presented in detail in our Annual Report.Report on Form 10-K for the year ended December 31, 2022.

Your vote is very important.    We encourage you to read all of the important information in the Proxy Statementproxy statement and vote your shares as soon as possible. Whether or not you plan to attend, you can be sure your shares are represented at the Annual Meeting by promptly submitting your voteproxy by the Internet, by telephone or, if you request a paper copy of the proxy materials and receive a proxy card, by mail.

On behalf of the Board of Directors, thank you for your continued confidence and investment in Quantum Computing.

 

Sincerely,

  

/s/ Robert Liscouski

  

Robert Liscouski

  

Chairman of the Board of Directors

 

Table of Contents

QUANTUM COMPUTING INC.

215 Depot Court SE, Suite 215
Leesburg, VA 20175
Telephone: (703) 436-2161436
-2161

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

to be held on Friday,Tuesday, November 12, 20217, 2023

To the Stockholders of Quantum Computing Inc.:

The 20212023 Annual Meeting of the Stockholders (the “Annual Meeting”) of Quantum Computing Inc., a Delaware corporation (together with its subsidiaries,(the “Company”, “Quantum Computing”, “we”, “us” or “our”), will be held on Friday,Tuesday, November 12, 2021,7, 2023, at 10:00 a.m. local time at the Company’s offices at 215 Depot Court SE, Suite 215, Leesburg, VA 20175. The purpose of the meeting is to consider and act upon the following matters:

1.      To elect fivesix directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified (Proposal No. 1);

2.      To approve, an amendment to the Company’s 2019 Equity and Incentive Plan (the “2019 Plan”) to increase the maximum number of shares of the Company’s common stock available for issuance under the 2019 Plan from 1,500,000 shares to 3,000,000 shares (Proposal No. 2);

3.      To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statementproxy statement with respect to the Annual Meeting (Proposal No. 3)2);

4.      To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company’s named executive officers (Proposal No. 4);

5.3.      To ratify the selection of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 20212023 (Proposal No. 5)3); and

6.4.      To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.

The foregoing items of business are more fully described in the Proxy Statement that is attached and made a part of this Notice.proxy statement with respect to the Annual Meeting. Only stockholders of record of the Company’s common stock, par value $0.0001 per share, (the “Common Stock”), at the close of business on Tuesday, September 20, 2021 (the “Record Date”)19, 2023, will be entitled to notice of, and to vote at, the Annual Meeting or any adjournment thereof.

All stockholders are cordially invited to attend the Annual Meeting. We are providing proxy material access to our stockholders via the Internet at www.proxyvote.com. Please give the proxy materials your careful attention.

BY ORDER OF THE BOARD OF DIRECTORS

/s/ Robert Liscouski

  

Robert Liscouski

  

Chief Executive Officer and Chairman of the
Board of Directors

Leesburg, VA

  

September 28, 202127, 2023

  

Table of Contents

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF SHAREHOLDERSSTOCKHOLDERS TO BE HELD ON TUESDAY, NOVEMBER 12, 20217, 2023

The Notice and Proxy Statementproxy statement and Annual Report on Form 10-K are available at www.proxyvote.com.

This Notice is not a votable ballot and presents only an overview of the more complete proxy materials, which contain important information and are available on the Internet as set forth above. You can also request a copy of the proxy materials, including the form of proxy, relating to the Annual Meeting by mail, free of charge, by requesting such materials prior to October 24, 2023. To request an email or regular mail copy of the proxy materials, you may (1) visit www.proxyvote.com., (2) call 1-800-579-1369 or (3) send an email to sendmaterial@proxyvote.com, including your control number (indicated on the proxy card) on your email subject line. You will not receive an email or paper copy of the proxy materials unless you submit such a request.

Your vote is important. We encourage you to review all of the important information contained in the proxy materials before voting.

 

Table of Contents

TABLE OF CONTENTS

 

Page

GENERAL INFORMATION ABOUT THE PROXY STATEMENT AND ANNUAL MEETING

 

1

Revocability of Proxies

1

Soliciting Proxies

1

Voting Securities

1

Voting of Proxies

2

Voting Procedures and Votes Required

2

Uninstructed Shares

2

Votes Required to Approve a Proposal

3

Tabulation and Reporting of Voting Results

3

Proxy Materials Are Available on the Internet

4

QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING

5

CORPORATE GOVERNANCE

 

95

Board of Directors

 

9

Board Committees

11

Code of Ethics

115

Delinquent Section 16(a) Reports

 

118

Board Meetings

8

Board Committees

9

Human Capital Management

12

EXECUTIVE COMPENSATION

 

15

Summary Compensation Table

 

15

Agreements with Named Executive Officers

 

15

Outstanding Equity Awards at Year End

 

1618

Director Compensation

 

1619

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

1721

Transactions with Related Persons

 

1922

AUDIT-RELATED MATTERS

 

2023

Audit Committee Report

 

2023

Audit Fees and Services

 

2124

Pre-Approval Policies and Procedures

 

2124

MATTERS TO BE VOTED ON

 

2225

Proposal 1: Election of Directors

 

2225

Proposal 2: Approve an Amendment to the 2019 Plan

23

Proposal 3: Non-Binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers

 

2926

Proposal 4: Non-Binding Advisory on the Frequency of Future Advisory Votes to Approve the Compensation of the Company’s Named Executive Officers

30

Proposal 5:3: Ratification of BF Borgers as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 20212023

 

3127

OTHER MATTERS

 

3228

Householding of Annual Meeting Materials

 

3230

i

Table of Contents

QUANTUM COMPUTING INC.
215 Depot Court SE, Suite 215
Leesburg, VA 20175
Telephone: (703) 436-2161

PROXY STATEMENT

ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON
TUESDAY, NOVEMBER 12, 20217, 2023

GENERAL INFORMATION ABOUT THE PROXY
STATEMENT AND ANNUAL MEETING

General

The enclosedThis proxy statement is furnished in connection withrelates to the solicitation of proxies by the Board of Directors (the “Board”) of Quantum Computing Inc. (the “Company,” “we”“we,” “us,” or “us”“our”), for use at the 20212023 Annual Meeting of the Company’s shareholdersstockholders (the “Annual Meeting”) to be held at 215 Depot Court SE, Suite 215, Leesburg, VA 20175, on Tuesday, November 12, 2021,7, 2023, at 10:00 a.m. local time, and at any adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. Accompanying this Proxy Statement is a proxy/voting instruction form (the “Proxy”) for the Annual Meeting, which you may use to indicate your vote as to the proposals contained in this Proxy Statement. Whether or not you expect to attend the meeting in person, please submit your proxy to vote your shares, in accordance with the instructions below, as promptly as possible to ensure that your vote is counted. It is contemplated that this Proxy StatementThis proxy statement and the accompanying form of Proxyproxy will first be mailedmade available to the Company’s shareholders on or about October 1, 2021.

Revocability of Proxies

All Proxies which are properly completed, signed and returned prior to the Annual Meeting, and which have not been revoked, will be voted in favor of the proposals described in this Proxy Statement unless otherwise directed. A shareholder may revoke his or her Proxy at any time before it is voted either by filing with the Chief Executive Officer of the Company, at its principal executive offices located at 215 Depot Court SE, Suite 215, Leesburg, VA 20175, a written notice of revocation or a duly-executed Proxy bearing a later date or by attending the Annual Meeting and voting in person.

Solicitation of Proxies

The Company will solicit stockholders by mail through its regular employees and will request banks and brokers and other custodians, nominees and fiduciaries, to solicit their customers who have stock of the Company registered in the names of such persons and will reimburse them for reasonable, out-of-pocket costs. In addition, the Company may use the service of its officers and directors to solicit proxies, personally or by telephone, without additional compensation.

Record Date

Shareholders of record at the close of business on September 20, 2021 (the “Record Date”), will be entitled to receive notice of, attend and vote at the meeting.

Voting Securities

As of September 20, 2021, there were 29,156,815 shares of Common Stock issued and outstanding, which constitutes all of the outstanding capital stock of the Company entitled to vote. Shareholders are entitled to one vote for each share of Common Stock held by them.

The presence in person or by proxy of the holders of a majority in interest of all stock issued and outstanding is necessary to constitute a quorum at this meeting. In the absence of a quorum at the meeting, the meeting may be postponed or adjourned from time to time without notice, other than announcement at the meeting, until a quorum is formed. The enclosed Proxy reflects the number of shares that you are entitled to vote. For purposes of the quorum and the discussion below regarding the vote necessary to take shareholder action, shareholders of record who are present at the Annual Meeting in person or by proxy and who abstain, including broker non-votes (as described below), and brokers holding customers’ shares of record who cause abstentions to be recorded at the meeting, are considered shareholders who are present for purposes of determining the presence of a quorum.

1

Table of Contents

Why am I being provided with these proxy materials?

We have delivered printed versions of these proxy materials to you by mail in connection with the solicitation by our Board of proxies for the matters to be voted on at our Annual Meeting and at any adjournment or postponement thereof.

What do I do if my shares are held in “street name”?

If your shares are held in a brokerage account or by a bank or other holder of record, you are considered the “beneficial owner” of shares held in “street name.” As the beneficial owner, you have the right to direct your broker, bank or other holder of record on how to vote your shares by following their instructions for voting. Please refer to information from your bank, broker or other nominee on how to submit your voting instructions.

What if other matters come up at the Annual Meeting?

At the date this Proxy Statement went to press, we did not know of any matters to be properly presented at the Annual Meeting other than those referred to in this Proxy Statement. If other matters are properly presented at the meeting or any adjournment or postponement thereof for consideration, and you are a stockholder of record and have submitted a proxy card, the persons named in your proxy card will have the discretion to vote on those matters for you.

Voting of Proxies

All valid proxies received prior to the Annual Meeting will be voted. The Board of Directors recommends that you vote by proxy even if you plan to attend the Annual Meeting. You can vote your shares by proxy via Internet or mail. To vote via Internet, go to www.proxyvote.com and follow the instructions. To vote by mail, fill out the enclosed Proxy, sign and date it, and return it in the enclosed postage-paid envelope to Broadridge Financial Solutions, Inc. Voting by proxy will not limit your right to vote at the Annual Meeting if you attend the Annual Meeting and vote in person. However, if your shares are held in the name of a bank, broker or other holder of record, you must obtain a proxy executed in your favor, from the holder of record to be able to vote at the Annual Meeting.

Voting Procedures and Vote Required

Your vote is important no matter how many shares you own.    Please take the time to vote. Take a moment to read the instructions below. Choose the way to vote that is easiest and most convenient for you, and cast your vote as soon as possible.

If you are the “record holder” of your shares, meaning that you own your shares in your own name and not through a bank, broker or other nominee, you may vote in one of three ways:

•        You may vote over the Internet.    You may vote your shares by following the “Vote by Internet” instructions on the accompanying proxy card. If you vote over the Internet, you do not need to vote by telephone or complete and mail your proxy card.

•        You may vote in Person.    You may vote your shares in person if you attend the Annual Meeting.

•        You may vote by mail.    If you requested a proxy card by mail, you may vote by completing, dating and signing the proxy card delivered and promptly mailing it in the postage-paid envelope provided. If you vote by mail, you do not need to vote over the Internet or by telephone.

Uninstructed Shares

All proxies that are executed or are otherwise submitted over the Internet or by telephone will be voted on the matters set forth in the accompanying Notice of Annual Meeting of Stockholders in accordance with the instructions set forth herein. However, if no choice is specified on a proxy as to one or more of the proposals, the proxy will be voted in accordance with the Board of Directors’ recommendations on such proposals as set forth in this proxy statement.

2

Table of Contents

Votes Required to Approve a Proposal

The holders of a majority in interest of all stock issued, outstanding and entitled to vote at a meeting, present in person or represented by proxy will constitute a quorum for the transaction of business at the Annual Meeting. Shares of common stock represented in person or by proxy (including shares which abstain or do not vote with respect to one or more of the matters presented for stockholder approval) will be counted for purposes of determining whether a quorum is present at the Annual Meeting. If a quorum is not present, the meeting may be adjourned until a quorum is obtained.

The following votes are required for approval of the proposals being presented at the Annual Meeting:

Proposal No. 1: Election of Directors.    Votes may be cast: “FOR ALL” nominees, “WITHHOLD ALL” nominees or “FOR ALL EXCEPT” those nominees noted by you on the appropriate portion of your proxy or voting instruction card. At the Meeting, five directors are to be elected, which number shall constitute our entire Board, to hold office until the next annual meeting of stockholders and until their successors shall have been duly elected and qualified. Pursuant to our bylaws, as amended, directors are to be elected by a majority of the votes of the shares present in person or represented by proxy at the Meeting and entitled to vote on the election of directors. This means that the five candidates receiving the highest number of affirmative votes at the Meeting will be elected as directors. Proxies cannot be voted for a greater number of persons than the number of nominees named or for persons other than the named nominees. Withholding a vote from a director nominee will not be voted with respect to the director nominee indicated and will have no impact on the election of directors although it will be counted for the purposes of determining whether there is a quorum. Broker non-votes will have no effect on the outcome of this proposal.

Proposal No. 2: To Approve an Amendment to the 2019 Plan.    Votes may be cast: “FOR,” “AGAINST” or “ABSTAIN.” The affirmative vote of the holders of shares of common stock representing a majority of the shares of Common Stock cast at the meeting in person or by proxy is required for the approval of the proposed amendment to the 2019 Plan to increase the number of shares of the Company’s common stock available for issuance under the 2019 Plan from 1,500,000 shares to 3,000,000 shares. Abstentions and broker non-votes will have no effect on the outcome of this proposal.

Proposal No. 3: To Approve the Compensation of the Company’s Named Executive Officers.    Votes may be cast: “FOR,” “AGAINST” or “ABSTAIN.” The affirmative vote of the holders of shares of common stock representing a majority of the shares of Common Stock cast at the meeting in person or by proxy is required for the approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying proxy statement. Abstentions and broker non-votes will have no effect on the outcome of this proposal.

Proposal No. 4: To Recommend the Frequency of Future Advisory Votes on Compensation.    Votes may be cast: “1 YEAR,” “2 YEARS,” “3 YEARS” or “ABSTAIN.” The selection of the three options presented receiving the highest number of votes for such option will be the option recommended by stockholders, on a non-binding advisory basis, for the frequency of future advisory votes on the compensation of the Company’s named executive officers. Abstentions and broker non-votes will have no effect on the outcome of this proposal.

Proposal No. 5: To Ratify the Selection of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December31, 2021.    Votes may be cast: “for,” “against” or “abstain.” the affirmative vote of the holders of shares of common stock representing a majority of the shares of Common Stock cast at the meeting in person or by proxy is required for the ratification of the selection of BF Borgers CPA PC as our independent registered public accounting firm for the current fiscal year. Abstentions will have no effect on the outcome of this proposal. There will be no broker non-votes with respect to this proposal.

Tabulation and Reporting of Voting Results

Preliminary voting results will be announced at the Annual Meeting. Final voting results will be tallied by the inspector of election after the taking of the vote at the Annual Meeting. The Company will publish the final voting results in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) within four business days following the Annual Meeting.

This proxy statement, the accompanying proxy card and our 2020 annual report to stockholders were first made available to stockholders on or about October 1, 2021.

3

Table of Contents

A copy of our Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission, or SEC, except for exhibits, will be furnished without charge to any stockholder upon written or oral request to Quantum Computing Inc., 215 Depot Court SE, Suite 215, Leesburg, VA 20175.

Proxy Materials Are Available on the Internet

The Company uses the Internet as the primary means of furnishing proxy materials to stockholders. We send a Notice of Internet Availability of Proxy Materials (the “Notice of Internet Availability” to our stockholders with instructions on how to access the proxy materials online at www.proxyvote.com or request a printed copy of materials.

Stockholders may follow the instructions in the Notice of Internet Availability to elect to receive future proxy materials in print by mail or electronically by email. We encourage stockholders to take advantage of the availability of the proxy materials online to reduce environmental impact and mailing costs.

4

Table of Contents

QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING

Why am I receiving these materials?

We have sent you these proxy materials because the Board is soliciting your proxy to vote at the Annual Meeting of Shareholders. According to our records, you were a shareholder of the Company as of the end of business on September 20, 2021.

You are invited to attend the Annual Meeting to vote on the proposals described in this Proxy Statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card.

The Company intends to mail these proxy materials on or about October 1, 2021 to all shareholders of record on the Record Date entitled to vote at the Annual Meeting.

What is included in these materials?

These materials include this proxy statement for the Annual Meeting and the proxy card.

What is the proxy card?

The proxy card enables you to appoint Robert Liscouski, our Chief Executive Officer, as your representative at the Annual Meeting. By completing and returning a proxy card, you are authorizing Mr. Liscouski to vote your shares at the Annual Meeting in accordance with your instructions on the proxy card. This way, your shares will be voted whether or not you attend the Annual Meeting.

When and where is the Annual Meeting being held?

The Annual Meeting will be held on November 12, 2021, commencing at 10:00 a.m., local time, at 215 Depot Court SE, Suite 215, Leesburg, VA 20175.

Can I view these proxy materials over the Internet?

Yes. The Notice of Meeting, this Proxy Statement and accompanying proxy card are available at www.proxyvote.com.

Who can vote at the Annual Meeting?

Only shareholders of record at the close of business on September 20, 2021 will be entitled to vote at the Annual Meeting. On this Record Date, there were 29,156,815 shares of Common Stock outstanding and entitled to vote.

27, 2023. The Annual Meeting will begin promptly at 10:00 a.m., local time. Check-in will begin one-half hour prior to the meeting. Please allow ample time for the check-in procedures.

ShareholderNotice of Record: Shares Registered in Your NameInternet Availability

If on September 20, 2021 your shares were registered directly in your name with Quantum Computing’s transfer agent, Worldwide Stock Transfer, LLC, then youThis year, pursuant to the U.S. Securities and Exchange Commission (the “SEC”) “Notice and Access” rules, we are a shareholderfurnishing our proxy materials to our stockholders over the Internet instead of record.mailing each of our stockholders paper copies of those materials. As a shareholderresult, we will send our stockholders by mail or email a Notice of record, you may vote in person atAnnual Meeting that includes a Notice of Internet Availability of Proxy Materials, which we sometimes refer to as the meeting or vote by proxy. Whether or not you plan“Notice,” containing instructions on how to attend the meeting, we urge you to fill out and return the enclosed proxy.

Beneficial Owner: Shares Registered in the Name of a Broker or Bank

If on September 20, 2021 your shares were held in an account at a brokerage firm, bank, dealer, or other similar organization, rather than in your name, then you are the beneficial owner of shares held in “street name” and theseaccess our proxy materials are being forwarded to you by that organization. The organization holding your account is considered to beover the shareholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent regardingInternet and how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the shareholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent.

5

Table of Contents

What am I voting on?

vote. The following matters are scheduled for a vote:

1.      To elect five directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified (Proposal No. 1);

2.      To approve an amendment to the Company’s 2019 Equity and Incentive Plan (the “2019 Plan”) to increase the maximum number of shares of the Company’s common stock available for issuance under the 2019 Plan from 1,500,000 shares to 3,000,000 shares (Proposal No. 2);

3.      To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement (Proposal No. 3);

4.      To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company’s named executive officers (Proposal No. 4);

5.      To ratify the selection of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (Proposal No. 5); and

6.      To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.

The BoardNotice is not currently aware of any other business that will be brought before the Annual Meeting.

How do I vote?

You may vote “For” or “Against” or abstain from voting. The procedures for voting are fairly simple:

Shareholder of Record: Shares Registered in Your Name

If you are a shareholder of record as of the Record Date, you may vote in person at the Annual Meeting or vote by proxy using the enclosed proxy card. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already voted by proxy.

•        To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. You should be prepared to present photo identification for admittance. A list of shareholders eligible to vote at the Annual Meeting will be available for inspection at the Annual Meeting and for a period of ten days prior to the Annual Meeting during regular business hours at our principal executive offices, which are located at 215 Depot Court SE, Suite 215, Leesburg, VA 20175.

•        To vote using the proxy card, simply complete, sign and date the enclosedor proxy card and return it promptly in the envelope provided. Ifcannot be used to vote your shares. The Notice also tells you returnhow to access your completed and signed proxy card to us beforevote on the Annual Meeting, we will vote your shares as you direct.

Beneficial Owner: Shares Registered in the Name of BrokerInternet or Bank

by telephone. If you arereceived a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received voting instructions with these proxy materials from that organization rather than from us. Simply complete and mail your voting instructions as directed by your broker or bank to ensure that your vote is counted. Alternatively, you may be able to vote by telephone or over the Internet by following instructions provided by your broker or bank. To vote in person at the Annual Meeting, you must obtain a valid proxy from your broker, bank, or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form.

How many votes do I have?

On each matter to be voted upon, you have one vote for each share of Common Stock you own as of the Record Date.

6

Table of Contents

What is a quorum for purposes of conducting the Annual Meeting?

The presence, in person or by proxy, of the holders of a majority in interest of all stock issued and outstanding, or 14,578,408 shares, entitled to vote at the meeting is necessary to constitute a quorum to transact business. If a quorum is not present or represented at the Annual Meeting, the shareholders entitled to vote thereat, present in person or by proxy, may adjourn the Annual Meeting from time to time without notice or other announcement until a quorum is present or represented.

What if I return a proxy card but do not make specific choices?

If you return a signed and dated proxy card without marking any voting selections, your shares will be voted “FOR” the election of the directors (Proposal No. 1), “FOR” approval of the amendment to the 2019 Plan (Proposal No. 2), “FOR” approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers (Proposal No. 3), to recommend that the frequency of future advisory votes on the compensation of the Company’s named executive officers will be “ONE YEAR”, “FOR” ratification of the appointment of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (Proposal No. 5), and “FOR” approval of any adjournment of the Annual Meeting, if necessary or appropriate, to transact such other business as may properly come before the meeting and all adjournments and postponements thereof; and if any other matter is properly presented at the meeting, your proxy holder (one of the individuals named on your proxy card) will vote your shares using his best judgment.

How does the Board recommend that I vote?

Our Board recommends that you vote your shares “FOR” the election of the directors (Proposal No. 1), “FOR” approval of the amendment to the 2019 Plan (Proposal No. 2), “FOR” approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers (Proposal No. 3), to recommend that the frequency of future advisory votes on the compensation of the Company’s named executive officers will be “ONE YEAR”, “FOR” ratification of the appointment of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (Proposal No. 5), and “FOR” approval of any adjournment of the Annual Meeting, if necessary or appropriate, to transact such other business as may properly come before the meeting and all adjournments and postponements thereof. Unless you provide other instructions on your proxy card, the persons named as proxy holders on the proxy card will vote in accordance with the recommendations of the Board as set forth in this Proxy Statement.

Who is paying for this proxy solicitation?

We will bear the cost of mailing and solicitation of proxies. Proxies may be solicitedNotice by mail or personally by our directors, officers or employees, none of whom will receive additional compensation for such solicitation. Those holding shares as of record for the benefit of others, or nominee holders, are being asked to distribute proxy soliciting materials to, and request voting instructions from, the beneficial owners of such shares. We will reimburse nominee holders for their reasonable out-of-pocket expenses.

What does it mean if I receive more than one set of proxy materials?

If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts. Please complete, sign and return each proxy card to ensure that all of your shares are voted.

I share the same address with another Quantum Computing Inc. shareholder. Why has our household only received one set of proxy materials?

The SEC’s rules permit us to deliver a single set of proxy materials to one address shared by two or more of our shareholders. This practice, known as “householding,” is intended to reduce the Company’s printing and postage costs. We have delivered only one set of proxy materials to shareholders who hold their shares through a bank, broker or other holder of record and share a single address, unless we received contrary instructions from any shareholder at that address. However, any such street name holder residing at the same address who wisheswould like to receive a separateprinted or email copy of the proxy materials, may make such aplease follow the instructions included in the Notice. You will not receive paper copies of the proxy materials by mail unless you have previously requested to receive these materials by mail, or you request the materials by contactingfollowing the bank, broker or other holderinstructions in the Notice. This process allows us to expedite our stockholders’ receipt of record, or Broadridge Financial Solutions, Inc. at 866-540-7095 or in writing at Broadridge, Householding Department, 51 Mercedes Way,

7

Tableproxy materials, lowers our costs of Contents

Edgewood, NY 11717. Street name holders residing atdistribution with respect to the same address who would like to request householdingproxy materials for the Annual Meeting, and reduces the environmental impact of Company materials may do so by contacting the bank, broker or other holder of record or Broadridge at the phone number or address listed above.Annual Meeting.

Can I change my vote after submitting my proxy?Revocability of Proxies

Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares, you may revoke your proxy in any one of three ways:

•        You may submit another properly completed proxy card with a later date;date or subsequently submit another proxy to vote your shares via the Internet or via telephone;

•        You may send a timely written notice that you are revoking your proxy to the Company at 215 Depot Court SE, Suite 215, Leesburg, VA 20175, Attn: Chief Executive Officer; or

•        You may attend the Annual Meeting and vote in person. Simply attending the meeting will not, by itself, revoke your proxy.

If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.

1

Table of Contents

How are votes counted?Solicitation of Proxies

VotesWe will bear the cost of solicitation of proxies. Proxies may be countedsolicited by the inspectormail or personally by our directors, officers, or employees, none of elections appointedwhom will receive additional compensation for such solicitation. Those holding shares of record for the benefit of others, or nominee holders, are being asked to distribute proxy soliciting materials to, and request voting instructions from, the beneficial owners of such shares. We will reimburse nominee holders for their reasonable out-of-pocket expenses.

Record Date; Stockholders Entitled to Vote

The holders of record of the outstanding shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at the close of business on Tuesday, September 19, 2023 (the “Record Date”), are entitled to receive notice of, attend, and vote at the Annual Meeting.

If on the Record Date your shares of Common Stock were registered directly in your name with Quantum Computing’s transfer agent, Worldwide Stock Transfer, LLC, then you are a stockholder of record. As a stockholder of record, you may vote in person at the meeting or vote by proxy.

Voting Securities; Quorum

As of the close of business on the Record Date, there were 75,094,943 shares of Common Stock issued and outstanding, which constitutes all of the outstanding capital stock of the Company entitled to vote at the Annual Meeting. Holders of Common Stock as of the Record Date are entitled to one vote for each share of Common Stock held by them as of the Record Date.

The presence, in person or by proxy, of the holders of one-third in voting power of all stock of the Company outstanding and entitled to vote at the Annual Meeting (or 25,031,648 shares of Common Stock) is necessary to constitute a quorum at the Annual Meeting. In the absence of a quorum at the meeting, the meeting may be adjourned from time to time without notice, other than announcement at the meeting, until a quorum is formed. The proxy card will reflect the number of shares that you are entitled to vote at the Annual Meeting. For purposes of the quorum and the discussion below regarding the vote necessary to take stockholder action, stockholders of record who will separately count “For,” “Abstainare present at the Annual Meeting in person or by proxy and Against” votes,who abstain, and broker non-votes. Abstentions will not be counted as votes (as described below), are considered stockholders who are present for any matter.purposes of determining the presence of a quorum.

Is my vote kept confidential?Voting Procedures

Proxy instructions, ballots and voting tabulations that identify individual shareholders are handled in a manner that protects your voting privacy. Your vote willis important no matter how many shares you own.    Please take the time to submit a proxy to vote your shares, even if you plan to attend the Annual Meeting and vote in person, to ensure that your shares are represented and voted at the meeting (including if your plans to attend change). Take a moment to read the instructions below. Choose the way that is easiest and most convenient for you, and submit a proxy to vote your shares as soon as possible.

If you are the “record holder” of your shares, meaning that you own your shares in your own name and not through a bank, broker, or other nominee, you may cause your shares to be disclosed either within the Company or to third parties, except:voted in one of four ways:

•        as necessaryYou may submit a proxy to meet applicable legal requirements;vote your shares over the Internet.    You may submit a proxy to vote your shares by visiting www.proxyvote.com and following the “Vote by Internet” instructions on the Notice.

•        You may submit a proxy to allow forvote your shares by telephone.    You may submit a proxy to vote your shares by visiting www.proxyvote.com and following the tabulation and certification of votes; and“Vote by Phone” instructions on the Notice.

•        You may submit a proxy to facilitatevote your shares by mail.    If you requested a successfulcopy of the proxy solicitation.

Occasionally, shareholders provide written comments on their proxy cards, which may be forwardedmaterials with respect to the Company’s managementAnnual Meeting by mail, you may cause your shares to be voted by completing, dating and signing your name (exactly as it appears on your proxy card) on the enclosed proxy card and mailing it in the postage-paid envelope provided.

•        You may vote in person.    You may vote your shares in person if you attend the Annual Meeting.

2

Table of Contents

Uninstructed Shares

All proxies that are executed and returned or are submitted over the Internet or by telephone will be voted on the matters set forth in the accompanying Notice in accordance with the instructions set forth therein. If no choice is specified as to one or more of the proposals, however, the proxy will be voted in accordance with the Board’s recommendations on such proposals as set forth in this proxy statement.

Shares Held in Street Name

If on the Record Date your shares of Common Stock were held in an account at a brokerage firm, bank, dealer, or other similar entity, rather than in your name, then you are the beneficial owner of shares held in what is referred to as “street name” and the Board.

How can I find outentity holding your account is considered to be the resultsstockholder of therecord for purposes of voting at the Annual Meeting?Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. As you are not the stockholder of record, however, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent.

You will receive instructions from the holder of record that you must follow in order for you to specify how your shares will be voted. If you do not specify how you would like your shares to be voted, your shares held in street name may still be voted but only by certain record holders and only with respect to certain matters. In general, under the rules of the various national and regional securities exchanges, holders of record have the authority to vote shares for which their customers do not provide voting instructions on certain limited routine, uncontested items, but not on non-routine proposals. In the case of non-routine or contested items for which instructions have not been provided, the institution holding street name shares cannot vote those shares. A broker “non-vote” occurs when we receive a proxy from a broker but the shares represented by such proxy are not voted on a particular matter because the broker has not received instructions from the beneficial owner or other persons entitled to vote shares on a particular matter with respect to which the broker does not have discretionary power to vote the shares. If your shares are held of record by a person or institution other than a broker, however, whether those shares can be voted without specific instructions from you will depend on your individual arrangement with that record holder, in particular, whether you have granted such record holder discretionary authority to vote your shares. In the absence of an arrangement with your record holder granting such discretionary authority, your record holder nominee will not have discretionary authority to vote your shares on any matter at the Annual Meeting in the absence of specific voting instructions from you.

The proposal to ratify the appointment of our independent registered public accounting firm is considered a “routine” item upon which brokerage firms may vote in their discretion on behalf of their clients if such clients have not furnished voting instructions. If your broker holder of record submits a proxy on your behalf, but does not indicate how your shares of Common Stock should be voted, the shares of Common Stock represented by such proxy will be voted FOR ratification of the appointment of BF Borgers CPA PC as our independent public accounting firm for 2023. The election of directors and the non-binding advisory vote to approve the compensation of our named executive officers are considered “non-routine” items for which brokerage firms may not vote in their discretion on behalf of clients who do not furnish voting instructions and, thus, there may be “broker non-votes” at the Annual Meeting with respect to these proposals. If you hold your shares in street name in a stock brokerage account, you must provide the record holder of your shares with instructions on how to vote your shares if you wish them to be voted on the election of directors and the non-binding advisory vote on our named executive officer compensation. If your shares are held in street name by a bank or other nominee, you must provide the record holder of your shares with instructions on how to vote your shares if you wish them to be voted on any matter at the Annual Meetingunless your shares are held of record by a bank or other nominee and you have an arrangement with the nominee granting such nominee discretionary authority to vote your shares.

Your vote is important. Accordingly, please sign and return your bank’s, broker’s, or other nominee’s instructions.

3

Table of Contents

Votes Required to Approve a Proposal

The following votes are required for approval of the proposals being presented at the Annual Meeting:

Proposal No. 1: Election of Directors.    Pursuant to our bylaws, directors are to be elected by a plurality of the votes cast at the Annual Meeting. This means that, assuming a quorum is present, the six candidates receiving the highest number of affirmative votes at the Annual Meeting will be elected as directors. Shares for which a vote is withheld from a director nominee will not be voted with respect to the director nominee indicated and will have no impact on the outcome of the election of directors, although such shares will be counted for the purposes of determining whether there is a quorum. Broker non-votes will have no effect on the outcome of the vote on this proposal.

Proposal No. 2: To Approve the Compensation of the Company’s Named Executive Officers.    The non-binding advisory proposal to approve the compensation of the Company’s named executive officers as disclosed in this proxy statement requires the approval of a majority of the votes cast on such proposal. Abstentions and broker non-votes, which are not considered votes cast, will have no effect on the outcome of the vote on this proposal.

Proposal No. 3: To Ratify the Selection of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.    Assuming a quorum is present, the proposal to ratify the selection of BF Borgers CPA PC as the Company’s independent registered public accounting firm for its current fiscal year requires the approval of a majority of the votes cast on such proposal. Abstentions are not considered as votes cast on this proposal and will have no effect on the outcome of the vote on this proposal. There will be no broker non-votes with respect to this proposal.

Tabulation and Reporting of Voting Results

Preliminary voting results will be announced at the Annual Meeting. Final voting results will be disclosedtallied by the inspector of election after the taking of the vote at the Annual Meeting. The Company will publish the final voting results in a Current Report on Form 8-K filed afterwith the SEC within four business days following the Annual Meeting.

84

Table of Contents

INFORMATION ABOUT THE BOARD AND CORPORATE GOVERNANCE

Executive Officers and Board of Directors

Set forth below are the names of and certain biographical information about each executive officer and member of our Board of Directors.the Board. The information presented includes each officer and director’s principal occupation and business experience for the past five years and the names of other public companies of which he or she has served as a director during the past five years.

The Board, of Directors, upon the recommendation of ourits Nominating and Corporate Governance Committee, has nominated:nominated Robert Liscouski, Christopher Roberts,Dr. Yuping Huang, Dr. Carl Weimer, Bertrand Velge, William J. McGann,Robert Fagenson, and Robert FagensonMichael Turmelle for election as directors, each to hold office until the next annual meeting of stockholders of the Company and until their successors are elected and qualified or until their earlier resignation or removal.

Name

 

Current
Age

 

Position

Robert Liscouski

 

6769

 

Chairman of the Board of Directors, President, and Chief Executive Officer (Principal Executive Officer)

Christopher RobertsChris Boehmler

 

6744

 

Chief Financial Officer (Principal Financial Officer) (Principal Accounting Officer),

William J. McGann

65

Chief Operating Officer and Chief Technology Officer

Dr. Yuping Huang

44

Chief Quantum Officer, Director

Bertrand VelgeDr. Carl Weimer

 

6261

 

Director

William J. McGann*Bertrand Velge

 

63

 

Director

Robert Fagenson

 

7274

Director

Michael Turmelle

64

 

Director

____________

*        Mr. McGann was appointed to the Board on September 22, 2021 following the Board’s acceptance of Mr. Schreiber’s resignation on the same date.

The following noteworthy experience, qualifications, attributes and skills for each Board member, led to our conclusion that the person should serve as a director in light of our business and structure:

Robert Liscouski has served as the Chairman and as President and Chief Executive Officer of Quantum Computing since co-founding the company in February 2018. Prior to joining Quantum Computing, Mr. Liscouski served as President of Implant Sciences Corp., a leader in the explosive trace detection industry, from December 2015 until its sale of its business assets and Chairman oftechnology to L3 Communications in August 2017. Mr. Liscouski also served on the Board of Directors of Implant Sciences from 2009-2015

. Mr. Liscouski age 67, iswas the Chairman and CEO of Quantum Computing. Mr. Liscouski is CEO and FounderManaging Director of Convergent Risk Group LLC, a provider of cyber risk analysis and a proven security professional, thought leader and successful entrepreneur withmitigation services for small to medium size companies, from June 2009 to March 2018. Mr. Liscouski has over 35 years of senior level security operational and company leadership experience in government and public and private companies.

Mr. Liscouski is a recognized Security Industry leader in assessing, mitigating and managing physical and cyber security risk in private sector enterprises and state and federal government agencies. Mr. Liscouski has extensive experience in leading innovative start up and turn around companies as well as building programs for large government organizations and is recognized as a leader in identifying emerging security technologies. Mr. Liscouski served as the Director of Information Assurance for The Coca-Cola Company during his employment there 1998-2003. During this time Mr. Liscouski, architected and implemented The Coca-Cola Company cyber security strategy. He also serves as a “Trusted Advisor”“trusted advisor” to senior officials within government and private sector,sectors, providing guidance in areas such as physical and cyber security, crisis management, organizational development and strategic planning. Mr. Liscouski’s career has spanned local law enforcement, senior government and private sector positions from operations to senior leadership and Boards of Directors. He was appointed by President George W. Bush as the first Assistant Secretary for Infrastructure Protection at the Department of Homeland Security upon the creation of the Department in 2003. In his capacity as Assistant Secretary for Infrastructure Protection, Mr. Liscouski was responsible for the implementation of the nation’s strategy and policy to protect US Critical Infrastructure to include Cyber Security. During his tenure he created the National Cyber Security Division which became what is today the Cyber Security and Infrastructure Agency of the Department of Homeland Security.

He started his career as an undercover and homicide investigator and Special Agent with the Diplomatic Security Service and progressed to senior federal government positions where he served as a senior advisor to the intelligence community and was appointed by President George W. Bush as the first Assistant Secretary for Infrastructure Protection at the Department of Homeland Security. He most recently was President of a public company that became a leader in the explosive trace detection industry culminating in the sale of the technology to L3 Communications.community. Mr. Liscouski is a frequent contributor to CNBC, CNN, Fox News, and other business and security media on Homeland Securityhomeland security and Terrorism issues.terrorism issues and served as a fellow for the Center of Strategic and International Studies (CSIS). Mr. Liscouski has a BS in Criminal Justice from John Jay College of Criminal Justice and a Master of Public Administration from the John F. Kennedy School of Government, Harvard University. His is a co-founder and Board Chairman of the National Child Protection Task Force, a 501c3 dedicated to the investigation of child sex trafficking and the recovery of sex trafficking victims.

5

Table of Contents

We believe that Mr. Liscouski’s service as Chief Executive Officer of several small public, high technology companies, his extensive leadership experience in government agencies, and his various corporate positions, as well as his expertise in cyber security and international work experience, make him qualified to serve on the Board.

Christopher Roberts, Chief Financial Officer and DirectorChris Boehmler

Mr. Roberts, age 67, is the Company’s Chief Financial Officer. Mr. Roberts has a law degreeBoehmler joined Quantum Computing Inc. as the Company’s Controller in March 2022. He worked as an independent consultant, from June 2018 until March 2022, serving both private and non-profit organizations. Previous to June 2018, his corporate finance experience totals 12 years in senior management positions for private and public technology-driven and financial institutions, primarily at Bridgewater Associates, LP and Intelsat. During this time, he also led the University of Virginia Law Schoolfinance functions for two special-purpose start-ups where he was instrumental in raising private equity and a B.S, in Electrical Engineeringperforming due diligence on acquisition targets. His financial expertise spans capital markets, planning & analysis, accounting operations, management and an M.B.A., both from the Massachusetts Institute of Technology. His M.B.A. was concentrated in Financeregulatory reporting, financial systems integrations, and Management of Technology.Sarbanes Oxley financial risks & controls. He started his career working in the investment banking division of Credit Suisse First Boston, followed by strategic management consulting for Raytheon Co. (a Fortune 500 company). Thereafter, he practiced law at two large NYC law firms. Since leaving the private practice of law,Booz Allen Hamilton. Mr. RobertsBoehmler has worked primarilyan undergraduate degree in financial management rolesEconomics with a numberminor in Germanic Studies from the University of government contractors in the aerospace, defense and Information technology sectors.

9

Table of Contents

Mr. Roberts has more than 37 years’ experience in public and private corporate finance and government contracting, including professional services, software products, and hardware manufacturing businesses. Mr. Roberts has served as the Chief Financial Officer of both public and private companies during the course of his career, including Secure Point Technologies, Systems Made Simple, Inc. (now a subsidiary of Leidos), Integral Systems Inc. (a publicly company traded on NASDAQ under the symbol “ISYS.” now a subsidiary of Kratos), and Pearson Analytic Solutions (now a subsidiary of General Dynamics). From 2012 to November 2016, he worked first as the CFO, and later as the President of Systems Made Simple, Inc., a wholly owned subsidiary of Leidos. Mr. Roberts is a co-author of Antitrust for Business, and has published articles on antitrust and patent law, space policy, information technology, and corporate finance.Chicago.

William J. McGann Director

Mr. McGann, age 63, was appointed to is the Board on September 22, 2021. Mr. McGann is presentlyCompany’s Chief Operating Officer, a position he has held since January 2022, and the Chief Technology Officer for the Security, Detection and Automation business at Leidos Corporation.Corporation from 2020 to 2022. Central to his role is the creation of innovative customer solutions driven by a strong portfolio of physics, chemistry, and software-based products. Mr. McGann has a strong, directed passion for transforming credible science into practical technology solutions in solving some of the world’s greatest challenges. Prior to joining Leidos, Mr. McGann held numerous business and technology leadership positions and roles including: (a) Founder of the first explosives trace detection company, Ion Track Instruments, (b) Chief Technology Officer for GE Security, (c) VP of Engineering for United Technologies Fire and Security business, (d) CEO and board member of Implant Sciences Corp., and (e) Chief Technology Officer at L3Harris Aviation Security and Detection business. Mr. McGann holds a Ph.D. in Chemical Physics from the University of Connecticut and undergraduate degrees in Chemistry and Biology.

Yuping Huang has served as the Company’s Chief Quantum Officer and a Director since June 2022. Dr. Huang has over 20 years of experience in commercial and academic settings, with pioneering research in a wide spectrum of quantum physics, optics, and technology. Prior to joining the Company, Dr. Huang founded QPhoton, Inc., which was a development stage company commercializing quantum photonic technology and devices to provide innovative and practical quantum solutions, and served as Chief Executive Officer and a director of QPhoton from January 2020 to June 2022, when QPhoton was acquired by the Company. Dr. Huang has been a Professor of Physics at the Stevens Institute of Technology, a private research technological university in Hoboken, New Jersey, since 2014 (from 2014 to 2019 as assistant professor, from 2019-2023 as associate professor and as a full professor since 2023). Dr. Huang is also the founding director of the Center for Quantum Science and Engineering at Stevens Institute of Technology. Dr. Huang received a Bachelor of Science in modern physics from the University of Science and Technology of China in 2004 and a PhD in quantum AMO physics in 2009 from Michigan State University.

We believe that Dr. Huang’s expertise in quantum computing and the quantum photonic technology that underlies the Company’s products, and his experience with the process of taking a theoretical concept and developing it into a viable product, qualify him to serve on the Board.

Dr. Carl Weimer has served as a director of the Company since January 2023. Dr. Weimer has over 25 years of experience in the aerospace industry. He has previously been involved in two companies in the aerospace industry, holding positions including Team Leader, Director of Research, Principal Investigator and Chief Technologist. From 1994 through 2000, Dr. Weimer was a Director of Research for Ophir Corporation, an aerospace optics company, and a partner in Chimera Geophysical LLC. From 2000 to 2018 he was a Team Leader for Ball Aerospace & Technologies Corp., a satellite company, on numerous NASA projects. He was awarded a NASA Distinguished Public Service Medal in 2008. Dr. Weimer has been the Chief Technologist for the Ball Civil Business Unit since 2018. In addition, Dr. Weimer has been the Principal Investigator for the NASA Earth Science Technology Office programs since 2008. Dr. Weimer received a Bachelor of Science degree from Harvey Mudd College (1984) and a Master of Science (1987) and a PhD (1992) from Colorado State University working with Dr. David Wineland at NIST, all in experimental Physics.

6

Table of Contents

We believe that Dr. Weimer’s experience with the design and manufacture of sophisticated photonic and optical instruments and systems, and his management expertise with complex U.S. government programs, make him qualified to serve on the Board.

Bertrand Velge has served as a Director

Mr. Velge, age 62, of the Company since 2018. He is the Managing Director of Graftyset, Ltd., a privately held company based in the United Kingdom. Graftyset is a wholesale distributor of wine, beer and other alcoholic and non-alcoholic beverage,beverages based in Sidcup, Kent (UK).the United Kingdom. Mr. Velge has served as Managing Director since the company was incorporated in 2003 under the name of Otterden Vintners, Ltd. Mr. Velge has also served as Director for Aliunde Ltd., a commodities trading firm based in the U.K., since 2005.2005, and as a director of LifeMD (Nasdaq: LFMD) since 2019. Mr. Velge has over twenty25 years of experience in multi-disciplinary venture investing and was managing director and co-founder of a fund that trades equities in Europe, Asia, and the USUnited States focusing on IPOs.initial public offerings. He speaks English, Flemish, and French, and is a graduate of the Universite Catholique de Louvain.

We believe that Mr. Velge’s extensive experience in international business management and investment, his experience with the public and private capital markets in the U.S. and Europe, and his management expertise with several small, growing companies to help guide corporate governance, qualify him to serve on the Board.

Robert Fagenson has served as a Director

of the Company since March 2021. Mr. Fagenson serveshas been the President of Fagenson & Co., Inc., a New York Stock Exchange (“NYSE”) member firm engaged in the specialist business on the trading floor of the NYSE, since 1975, and the Branch Owner of a B Riley Wealth Management branch since 2021. He was Vice Chairman of National Holdings Corporation (“NHLD”), a publicly traded holding company, listed on The Nasdaq Stock Market LLC (“Nasdaq”), from 2012 to 2020. He served as a member of the board of directors of National Holdings Corporation (“NHS”NHLD”) since March 2012. He servesfrom 2012 to 2020 and as vice chairman of the board of directors of NHS since September 2016.NHLD from 2016 to 2020. Mr. Fagenson previously served as co-chief executive officer of NHSNHLD from January 3, 2017 to January 31, 2017, as chief executive officer and chairman of the board of directors of NHSNHLD from December 2014 to September 2016, and as executive vice-chairman of the board of directors of NHSNHLD from July 2012 to December 2014. Mr. Fagenson has been a branch owner at NHS,National Securities Corporation (“NSC”), a registered broker dealer and full line brokerage firm, which was an operating companydivision of NHS,NHLD, since 2012, and president of Fagenson & Co., Inc., a family investment company, since 1982.2012. Mr. Fagenson spent the majority of his career at the New York Stock Exchange (NYSE), where he was managing partner of one of the exchange’s largest specialist firms.NYSE. While at the NYSE, Mr. Fagenson served as a governor on the trading floor and was elected to the NYSE board of directors in 1993, where he served for six years, eventually becoming vice chairman of the NYSE board of directors from 1998 to 1999 and 2003 to 2004. Mr. Fagenson has served as director of the New York City Police Museum since 2005 and as director of the Federal Law Enforcement Officers Association Foundation since 2009. He has also served on the board of directors of Sigma Alpha Mu Foundation since 2011 and on the board of directors of New York Edge since 2015. In addition, Mr. Fagenson served as the non-executive chairman of Document Security Systems, Inc. from 2012 to 2018 (NYSEMKT:(NYSE: DSS). He is currently a member of the alumni boardsboard of the Whitman School of Business at Syracuse University.

Mr. Fagenson received his B.S. in Transportation Sciences & Finance from Syracuse University in 1970. The Board believes

We believe that Mr. Fagenson’s extensive knowledge of, and experience working in, the public and private capital markets, his years of experience in corporate management and his detailed knowledge of auditing and financial statements and financial controls qualify him to serve on the securities industry and knowledgeBoard.

Michael Turmelle has served as a Director of the Company since December 2021. Since 2017, Mr. Turmelle has served as its former chief executive officer qualifies himthe Managing Director of Hayward Tyler, which he joined in 2015. Hayward Tyler, a 225-year-old international engineering company, designs, manufactures, and services performance-critical electric motors and pumps to servemeet the most demanding of applications for the global energy industry, as a memberboth an original equipment manufacturer supplier and trusted partner. Previously, Mr. Turmelle ran his own consulting company, working with start-ups and turn-arounds in the areas of renewable energy, medical, and other advanced technologies. Mr. Turmelle has served on numerous Boards of Directors including the Board of Directors of Implant Sciences Corp., an explosive and narcotic trace detection company, where he served as Chairman of the board.Board from 2015 to 2017. Mr. Turmelle was also Chief Financial Officer and Chief Operating Officer of SatCon Technology Company, a technology development company focusing on energy and power applications for a wide range of markets. SatCon spun out of the Charles Stark Draper Laboratory at MIT in 1985. Mr. Turmelle served on SatCon’s Board of Directors from 1992, when he helped take the company public, until 2005. Mr. Turmelle was also on the board of directors of Beacon Power, a SatCon spin-off company dealing in flywheel energy storage, from 1996 to 2000. Mr. Turmelle currently is Chairman

107

Table of Contents

of the Board of Ideal Power Inc., developer of an innovative, proprietary semiconductor power switch. Mr. Turmelle has a BA in Economics from Amherst College and is a graduate of General Electric’s Financial Management Program. Mr. Turmelle brings to the Board years of public company executive experience as well as extensive experience in finance and operations and in the field of electrical technology.

We believe that Mr. Turmelle’s extensive knowledge and experience in the management of technology focused public companies and the commercialization of advanced technologies, his years of experience serving on boards of public companies, and his expertise in financial statement preparation, audits and financial controls, makes him qualified to serve on the Board.

Family Relationships

There are no family relationships between any of our directors orand executive officers.

Delinquent Section 16(a) Beneficial Ownership Reporting ComplianceReports

Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), requires the Company’s executive officers and directors, and persons who own more than 10% of the Company’s common stock,Common Stock, to file reports of ownership and changes in ownership on Forms 3, 4 and 5 with the SEC.

Based solely on the Company’s review of the copies of such Forms, and written representations from certain reporting persons, the Company believes that all filings required to be made by the Company’s Section 16(a) reporting persons were made during the Company’s fiscal year ended December 31, 20202022, with the exception of two Forms 4 that should have been filed to report stock sales by Robert Liscouski made in November 2022 (10,000 shares of Common Stock) and December 2022 (5,000 shares of Common Stock), which were madenot reported on a timely basis.Form 4 until July 7, 2023.

Code of EthicsBoard Meetings; Attendance at Annual Meetings

The Company currently maintainsBoard met 12 times during the year ended December 31, 2022. Each Director attended at least 75% of the total number of meetings of the Board and the Board committees of which he was a Code of Ethics which applies tomember during 2022.

While the Board does not have a formal policy, all directors officers, and employees. A copyare encouraged to attend our annual meetings of stockholders. One of our Codefive then-serving Board members attended our 2022 annual meeting of Ethics can be found on our website at www.quantumcomputinginc.com.stockholders.

Board Composition and Determination of Director Independence

Our board of directorsThe Board consists of fivesix members. The directors will serve until our next annual meeting and until their successors are duly elected and qualified. The Company defines “independent”Rule 5605 of the Nasdaq Listing Rules requires a majority of a listed company’s board of directors be composed of independent directors. In addition, the Nasdaq Listing Rules require that, subject to specified exceptions, each member of a listed company’s audit, compensation, and nominating and corporate governance committees be independent, and that compensation and audit committee members also satisfy additional independence criteria under the Exchange Act. Compensation committee members also should qualify as “non-employee directors” under Rule 16b-3 of the Exchange Act.

Based upon information requested from and provided by each director concerning his background, employment and affiliations, including family relationships, the Board has determined that termexcept for Robert Liscouski and Yuping Huang, each director who served at any time during or since 2022 is an “independent director” as defined inunder Rule 5605(a)(2) of the NASDAQ listing standards.

Nasdaq Listing rules. The Board also determined that Robert Fagenson, Michael Turmelle and Bertrand Velge, who currently constitute our Audit Committee and Compensation Committee, satisfy the independence and other qualifications standards for such committees established by the SEC and Nasdaq Listing rules, as applicable. In making such determinations, the determination of whether a member ofBoard considered the board is independent,relationships that each such non-employee director has with our board considers, amongCompany and all other things, transactionsfacts and relationships between each director and his immediate family and the Company, including those reported under the caption “Certain Relationships and Related-Party Transactions”. The purpose of this review is to determine whether any such relationships or transactions are material and, therefore, inconsistent with a determinationcircumstances that the directors are independent. On the basisBoard deemed relevant in determining independence.

8

Table of such review and its understanding of such relationships and transactions, our board affirmatively determined that Bertrand Velge, William J. McGann and Robert Fagenson are qualified as independent and that they have no material relationship with us that might interfere with his or her exercise of independent judgment.Contents

Board Committees; Audit Committee Financial Expert; Stockholder Nominations

Our board of directorsThe Board has established an audit committee, a compensation committee, and a nominating and corporate governance committee, and a risk committee. Each committee has its own charter, which is available on our website at www.quantumcomputinginc.com. Each of the boardBoard committees has the composition and responsibilities described below.

The following table identifies the committee members:

Name

Audit

Compensation

Nominating and Corporate Governance

Risk

Independent

Robert Fagenson

Chairman

X

X

X

Michael Turmelle

X

Chairman

X

X

X

Bertrand Velge

X

X

Chairman

X

Carl Weimer

X

X

Robert Liscouski

Chairman

Yuping Huang

Robert Fagenson is an “audit committee financial expert,” as such term is defined in Item 407(d)(5) of SEC Regulation S-K.

Members will serve on these committees until their resignation or until otherwise determined by our Board of Directors.

Bertrand Velge, William J. McGann and Robert Fagenson are our independent directors.

The members of each committee are, as follows:

Audit Committee: Bertrand Velge, William J. McGann and Robert Fagenson with Mr. Fagenson serving as the Chairman. Our Board has determined the Mr. Fagenson is currently qualified as an “audit committee financial expert”, as such term is defined in Item 407(d)(5) of Regulation S-K.Board.

Compensation Committee: Bertrand Velge, William J. McGann and Robert Fagenson. Mr. McGann serves as Compensation Committee Chairman.

Nominating and Governance Committee: Bertrand Velge, William J. McGann and Robert Fagenson. Mr. Velge serves as Chairman of the Nominating and Governance Committee.

11

Table of Contents

Audit Committee

The Audit Committee oversees our accounting and financial reporting processes and overseeoversees the audit of our consolidated financial statements and the effectiveness of our internal control over financial reporting. The specific functions of this Committee include, but are not limited to:

•        selecting and recommending to our board of directors the appointment of an independent registered public accounting firm and overseeing the engagement of such firm;

•        approving the fees to be paid to the independent registered public accounting firm;

•        helping to ensure the independence of the independent registered public accounting firm;

•        overseeing the integrity of our financial statements;

•        preparing an audit committee report as required by the SEC to be included in our annual proxy statement;

•        resolving any disagreements between management and the auditors regarding financial reporting;

•        reviewing with management and the independent auditors any correspondence with regulators and any published reports that raise material issues regarding the Company’s accounting policies;

•        reviewing and approving all related-party transactions; and

•        overseeing compliance with legal and regulatory requirements.

Compensation Committee

OurThe Compensation Committee assists the board of directorsBoard in the discharge of its responsibilities relating to the compensation of the boardmembers of directorsthe Board and our executive officers.

The Committee’s compensation-related responsibilities include, but are not limited to:

•        reviewing and approving on an annual basis the corporate goals and objectives with respect to compensation for our Chief Executive Officer;

•        reviewing, approving, and recommending to our board of directorsthe Board on an annual basis the evaluation process and compensation structure for our other executive officers;

9

Table of Contents

•        determining the need for and the appropriateness of employment agreements and change in control agreements for each of our executive officers and any other officers recommended by the Chief Executive Officer or board of directors;the Board;

•        providing oversight of management’s decisions concerning the performance and compensation of other companyCompany officers, employees, consultants, and advisors;

•        reviewing our incentive compensation and other equity-based plans and recommending changes in such plans to our board of directorsthe Board as needed, and exercising all the authority of our board of directorsthe Board with respect to the administration of such plans;

•        reviewing and recommending to our board of directorsthe Board the compensation of independent directors, including incentive and equity-based compensation; and

•        selecting, retaining, and terminating such compensation consultants, outside counsel, or other advisors as it deems necessary or appropriate.

Compensation Committee members are appointed annually by the Board on the recommendation of the Nominating and Corporate Governance Committee, and may be replaced by the Board. In performing their responsibilities, Compensation Committee members are entitled to rely in good faith on information, opinions, reports or statements prepared or presented by officers, employees, counsel, independent auditors, other committees of the Board, or other persons.

The Compensation Committee acts under a written charter adopted and approved by our Board and may, in its discretion, obtain the assistance of outside advisors, including legal counsel, independent auditors, or other persons. In determining each component of executive and director compensation, the Compensation Committee generally considers each of the following factors: industry compensation data, individual performance and contributions, company financial and operational performance, company strategic positioning, and total executive compensation.

Nominating and Corporate Governance Committee

The purpose of the Nominating and Corporate Governance Committee is to recommend to the boardBoard nominees for election as directors and persons to be elected to fill any vacancies on the board,Board, develop and recommend a set of corporate governance principles, and oversee the performance of the board.Board.

12

Table of Contents

The Committee’s responsibilities include:

•        recommending to the board of directorsBoard nominees for election as directors at any meeting of stockholders and nominees to fill vacancies on the board;Board;

•        considering candidates proposed by stockholders in accordance with the requirements in the Committee charter;

•        overseeing the administration of the Company’s code of business conduct and ethics;

•        reviewing with the entire board of directors,Board, on an annual basis, the requisite skills and criteria for boardBoard candidates and the composition of the boardBoard as a whole;

•        the authority to retain search firms to assist in identifying boardBoard candidates, approve the terms of the search firm’s engagement, and cause the Company to pay the engaged search firm’s engagement fee;

•        recommending to the board of directorsBoard on an annual basis the directors to be appointed to each committee of the board of directors;Board;

•        overseeing an annual self-evaluation of the board of directorsBoard and its committees to determine whether it and its committees are functioning effectively; and

•        developing and recommending to the boardBoard a set of corporate governance guidelines applicable to the Company.

The Nominating and Corporate Governance Committee may delegate any of its responsibilities to subcommittees as it deems appropriate. The Nominating and Corporate Governance Committee is authorized to retain independent legal counsel and other advisors, and conduct or authorize investigations into any matter within the scope of its duties.

Code of Business Conduct and Ethics

We have adopted a code of business conduct and ethics applicable to our principal executive, financial and accounting officers and all persons performing similar functions. A copy of that code is available on our corporate website at www.quantumcomputinginc.com. We expect that any amendments to such code, or any waivers of its requirements, will be disclosed on our website.

Disclosure of Commission Position on Indemnification of Securities Act Liabilities

Our directors and officers are indemnified as provided by the Delaware corporate law and our bylaws. We have agreed to indemnify each of our directors and certain officers against certain liabilities, including liabilities under the Securities Act. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the provisions described above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than our payment of expenses incurred or paid by our director, officer or controlling person in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

We have been advised that in the opinion of the SEC indemnification for liabilities arising under the Securities Act is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of our legal counsel the matter has been settled by controlling precedent, submit the question of whether such indemnification is against public policy to a court of appropriate jurisdiction. We will then be governed by the court’s decision.

1310

Table of Contents

The Nominating and Corporate Governance Committee will consider all recommendations for nominations to the Board from any person (or group) who has (or collectively if a group have) held more than 3% of the Company’s voting securities for longer than one year. Stockholders desiring to submit such recommendations to the Nominating and Corporate Governance Committee should submit information regarding such recommendation, consistent with the information that would be required for direct stockholder nominations of directors (see “Stockholder Proposals”), in writing or by electronic mail to the Chair of the Nominating and Corporate Governance Committee, at: Quantum Computing Inc., Attention Chairman, Nominating and Corporate Governance Committee, 215 Depot Court SE, Suite 215, Leesburg, VA 20175 or investors@quantumcomputinginc.com. When the required information has been received, the Committee will evaluate the proposed nominee, with the principal criteria being the needs of the Company and the qualifications of such proposed nominee to fulfill those needs. There are no differences in the manner in which the nominating committee evaluates nominees for director based on whether the nominee is recommended by a stockholder.

Risk Committee

The purpose of the Risk Committee is to assist the Board in the oversight of the Company’s management of key risks, including strategic and operational risks relating to intellectual property, data security, and related legal and compliance risks. Oversight of financial risks remains the responsibility of the Audit Committee.

The Committee’s responsibilities include:

•        reviewing and discussing with management the Company’s risk governance structure, risk assessment and risk management practices, the guidelines, policies, and processes for risk assessment and risk management, and the effectiveness of applicable risk management frameworks with respect to key risks, including with respect to intellectual property and data security;

•        Reviewing and discussing with management the Company’s strategy relating to key risks, including strategic and operational risks and legal and compliance risks, including with respect to intellectual property and data security, and in relation to its identification and assessment of threats (including those arising out of unauthorized access, use or disclosure of confidential, sensitive, or proprietary information or data), and the enforcement of policies, protocols, and procedures relating to confidentiality and restrictions on the access, use or disclosure of confidential, sensitive, or proprietary information or data;

•        assessing whether mitigation programs and initiatives with respect to key risks are fulfilling their purpose or require any modification;

•        reviewing reports on selected risk topics as the Committee deems appropriate from time to time; and

•        discharging any other duties or responsibilities delegated to the Committee by the Board.

Involvement in Certain Legal Proceedings.Proceedings

Our Chief Executive Officer, Mr. Robert Liscouski, was President of Implant Sciences Corporation, which filed a petition for bankruptcy on October 11, 2016 in the Delaware Bankruptcy Court.

With the exception of the foregoing, to the best of our knowledge, none of our directors or executive officers has, during the past ten10 years:

•        been convicted in a criminal proceeding or beenis a named subject toof a pending criminal proceeding (excluding traffic violations and other minor offenses);

•        had any bankruptcy petition filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for, the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;

11

Table of Contents

•        been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;

•        been found by a court of competent jurisdiction in a civil action or by the Securities and Exchange CommissionSEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

•        been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

•        been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

ExceptHuman Capital Management

Board of Directors Oversight

The Board recognizes the critical importance of our team and the necessity to ensure a diverse, inclusive, and creative work environment that is centered around a values-based culture. The Board meets regularly with management to discuss issues impacting our team members and ways to support our workforce. Our focus on culture comes from the Board and flows throughout the Company. In evaluating our Chief Executive Officer and management team, emphasis is put on their contributions to our overall culture.

Our Team and Culture

Our mission, to be the democratizing force that brings quantum solutions to business, academia, government, and ultimately individual users, is integral to our culture and how we build amazing teams and products to lead our industry. We enable remote work through our hybrid work model, which allows in-person collaboration as set forthneeded and the efficiency of remote work for other tasks. Our team consists of corporate employees, independent contractors, and consultants. Our team members are distributed around the world, and while we have several corporate offices, we do not rely solely on in-person collaboration. Our team works with a variety of tools and has adopted practices to ensure that all voices are heard, innovation is fostered, and results are achieved. Our hybrid team, and its belief in our discussion belowmission, values, and vision, is critical to our success. With the consistent investment in “Certain Relationships and Related Transactions,” nonethe development of our team and our commitment to diversity, inclusion, and belonging, we have worked to cultivate an environment where people are able to be themselves at work and perform to the best of their abilities.

Our People

Our mission not only drives the creation and continuous development of our work marketplace, it is integral to how we engage our employees and our approach to creating and fostering an inclusive environment that promotes and encourages diversity, inclusion, belonging, career development, and wellness.

Diversity, Inclusion, and Belonging

We view belonging as a feeling, inclusion as a practice, and diversity as an outcome.

We foster belonging through our communities-groups that build empathy and promote inclusive skill-building. We cultivate inclusion by equipping managers with tools to effectively build and lead amazing and inclusive teams that amplify team members’ voices. Additionally, we practice multidimensional compensation and mobility reviews during

12

Table of Contents

our annual employee performance evaluation process. This is led by a cross-functional team of human resource and legal leaders to help ensure that we are fair in our rewards and recognition strategy. Diversity, inclusion, and belonging is a journey, not a destination and, as such, we will continue to explore ways to cultivate an inclusive culture where every team member belongs.

Training and Development

As an organization built on individualized talents and skills, we understand the value of providing our employees with ongoing professional development so that they can advance their careers. We offer our employees an array of on-line learning opportunities, including a variety of training classes.

Benefits and Competitive Compensation

We strive to offer market-competitive compensation and benefits to attract and retain employees for the long term. We provide total rewards that attract and retain world-class employees through a total compensation package that includes equity-based awards to align employee compensation with stockholder interests. Knowing that our employees have diverse needs and life priorities, we also provide comprehensive benefits and services to those eligible, which include core benefits such as medical, dental, vision, and disability insurance, in addition to benefits tailored to the specific needs of our employees, such as mental health, fertility, family back-up care, and adoption support. We offer a health savings account with Company contributions, flexible working schedules, paid holidays, and unlimited vacation policies. We sponsor a 401(k) plan that includes a matching contribution.

Organizational Wellbeing

We engage our workforce in meaningful ways and take timely action in response to their feedback. Research into workforce experience begins during onboarding and is sustained throughout a team member’s tenure at Quantum Computing. This “life cycle” approach to workforce research affords our senior leadership and human resources team members ongoing and real-time insight into critical moments of worker experience and productivity. The collection of such data allows leadership, line managers, and our human resources team to identify successes and opportunities at multiple levels, including for individual team members, and company-wide programs. Over time, the aggregation and analysis of such data enables us to optimize for those workforce factors that drive crucial people and business outcomes.

Employee Wellness

Employee safety and wellbeing is of paramount importance to us. We provide productivity and collaboration tools and resources for employees, including training and tool kits to help leaders effectively lead and manage remote and in-person teams. In addition, we promote programs to support our employees’ physical, financial, and mental wellbeing. For example, we regularly conduct internal surveys to assess the wellbeing and needs of our employees, and we offer employee assistance and mindfulness programs to help employees and their families manage anxiety, stress, sleep, and overall wellbeing. We believe that our employees are at their best when they take the time to recharge. In order to encourage our employees to recharge and make their wellbeing a priority, we provide unlimited paid time off in addition to our company-recognized holidays.

Shareholder Communications

The Board welcomes communications from our stockholders, and it is our policy to facilitate communication from stockholders. The Board generally believes it is in our best interests that designated members of management speak on behalf of the Company. Stockholders and other interested parties wishing to communicate with the Board or with an individual member of the Board concerning the Company may do so by writing to the Board of Directors or to a particular member of the Board of Directors, by mailing such correspondence to Quantum Computing Inc., Attention Corporate Secretary, 215 Depot Court SE, Suite 215, Leesburg, VA 20175.

Please indicate on the envelope or in the email whether the communication is from a stockholder or other interested party. The Board has instructed the Corporate Secretary and other relevant members of management to examine incoming communications and forward to the Board or individual Board members as appropriate, communications

13

Table of Contents

he or she deems relevant to the Board’s roles and responsibilities. The Board has requested that certain types of communications not be forwarded, and redirected if appropriate, such as spam, business solicitations or advertisements, resumes or employment inquiries, service complaints or inquiries, surveys, or any threatening or hostile materials.

Board Leadership Structure and Board’s Role in Risk Oversight

Robert Liscouski, who serves as our President and Chief Executive Officer, is our Chairman of the Board. The Chairman has authority, among other things, to preside over and set the agenda for Board meetings. Accordingly, the Chairman has substantial ability to shape the work of the Board. We believe that the presence of four independent members of the Board ensures appropriate oversight by the Board of our business and affairs. However, no single leadership model is right for all companies and at all times. The Board recognizes that depending on the circumstances, other leadership models, such as the appointment of a lead independent director, might be appropriate. Accordingly, the Board may periodically review its leadership structure. In addition, the Board holds executive sessions in which only independent directors are present.

The Board is generally responsible for the oversight of corporate risk in its review and deliberations relating to our activities. Our principal source of risk falls into two categories, financial and product commercialization.

Our Audit Committee oversees the management of financial risks; our Board regularly reviews information regarding our cash position, liquidity and operations, as well as the risks associated with each. The Board regularly reviews plans, results and potential risks related to our business, growth, and strategies. Our Compensation Committee oversees risk management as it relates to our compensation plans, policies and practices for all employees including executives and directors, particularly whether our compensation programs may create incentives for our employees to take excessive or executiveinappropriate risks that could have a material adverse effect on the Company.

Officer and Director Hedging

We maintain a policy on insider trading that applies to all shares of our capital stock held by any director, officer or employee. The policy requires that all directors, officers has been involvedand employees receive our pre-clearance before engaging in any transactions involving our shares of capital stock and prohibits all directors, officers or employees from taking part in any hedging transactions.

Board Diversity Matrix

The following matrix summarizes self-identified diversity characteristics and is provided in accordance with us or any of our directors, executive officers, affiliates or associates which are required to be disclosed pursuant to the rules and regulations of the Commission.applicable Nasdaq listing Requirements:

BOARD DIVERSITY MATRIX AS OF SEPTEMBER 26, 2023

Total Number of Directors

6

Female

Male

Non-Binary

Did Not
Disclose Gender

Part I: Gender Identity

Directors

6

Part II: Demographic Background

African American or Black

0

Alaskan Native or Native American

0

Asian

1

Hispanic or Latinx

0

Native Hawaiian or Pacific Islander

0

White

5

Two or More Races or Ethnicities

LGBTQ+

0

Did Not Disclose Demographic Background

0

14

Table of Contents

EXECUTIVE COMPENSATION

Summary Compensation Table

The following summary compensation table sets forth all compensation awarded to, earned by, or paid to the namedCompany’s executive officers paidset forth in the table (the “named executive officers” or “NEOs”) by us during the years ended December 31, 20202022 and 2019.2021.

Name and Principal Position

 

Year

 

Salary
($)

 

Bonus
($)

 

Stock
Awards
($)

 

Option
Awards
($)

 

Non-Equity
Incentive Plan
Compensation
($)

 

Non-Qualified
Deferred
Compensation
Earnings
($)

 

All Other
Compensation
($)

 

Total
($)

Robert Liscouski
Chief Executive
Officer (PEO)

 

2020

 

360,000

 

40,000

 

1,264,000

 

75,000

 

0

 

0

 

0

 

1,739,000

2019

 

360,000

 

0

   

0

 

0

 

0

 

0

 

360,000

  

 

 

 

 

 

 

 

Christopher Roberts Treasurer (PFO)

 

2020

 

202,750

   

1,264,000

 

45,000

 

0

 

0

 

0

 

1,511,750

2019

 

175,237

 

0

   

0

 

0

 

0

 

0

 

175,237

  

 

 

 

 

 

 

 

SUMMARY COMPENSATION TABLE

Name and Principal Position

 

Year

 

Salary
($)

 

Bonus
($)

 

Stock
awards
($)

 

Option
awards
($)(4)

 

Nonequity
incentive
plan
compensation
($)

 

Nonqualified
deferred
compensation
earnings
($)

 

All other
compensation
($)

 

Total
($)

Robert Liscouski

 

2022

 

402,839

 

180,000

 

0

 

4,510,500

 

0

 

0

 

0

 

 

5,093,339

Chief Executive Officer

 

2021

 

361,900

 

190,000

 

0

 

1,712,500

 

0

 

0

 

0

 

 

2,264,400

    

 

 

 

 

 

 

 

 

Christopher Roberts(1)

 

2022

 

303,810

 

52,853

 

0

 

1,185,000

 

0

 

0

 

0

 

 

1,541,663

Treasurer, Secretary and former Chief Financial Officer

 

2021

 

214,170

 

0

 

0

 

2,740,000

 

0

 

0

 

0

 

 

2,954,170

    

 

 

 

 

 

 

 

 

William J. McGann

 

2022

 

403,768

 

250

 

0

 

3,654,000

 

0

 

0

 

0

 

 

4,058,018

Chief Operating Officer and

 

2021

 

0

 

0

 

0

 

0

 

0

 

0

 

22,903

(2)

 

22,903

Chief Technology Officer

   

 

 

 

 

 

 

 

 

David Morris,

 

2022

 

416,415

 

69,578

 

0

 

118,500

 

0

 

0

 

0

 

 

604,493

Chief Revenue Officer

 

2021

 

263,945

 

0

 

0

 

1,340,000

 

0

 

0

 

0

 

 

1,603,945

    

 

 

 

 

 

 

 

 

Dr. Yuping Huang,

 

2022

 

216,830

 

0

 

0

 

948,000

 

0

 

0

 

0

 

 

1,164,830

Chief Quantum Officer(3)

                

 

  

____________

(1)      Mr. Roberts resigned from this position as Chief Financial Officer on June 30, 2023.

(2)      Consists of $17,903 for consulting services provided to the Company during 2021 and $5,000 for director fees paid in cash for Mr. McGann’s service on the Board during 2021.

(3)      Dr. Huang was appointed Chief Quantum Officer of the Company on June 15, 2022.

(4)      Amounts reflect the aggregate grant date fair value of stock options, computed in accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 718, Stock Compensation. These amounts do not reflect the actual economic value that will be realized by the employee upon the vesting, settlement or exercise of the stock option and/or stock award. The assumptions that we used to calculate these amounts are discussed in the Notes to our audited consolidated financial statements for the fiscal year ended December 31, 2022 included in our Annual Report on Form 10-K filed with the SEC on March 29, 2023. Stock options typically have a duration of five years from the date of grant, vest over a period of three years, and are exercisable after vesting upon payment of the exercise price. For more details, see “Outstanding Equity Awards at Fiscal Year End.”

Executive Employment Agreements

Mr.Robert Liscouski Employment Agreement

WeAs of April 26, 2021, the Company entered into an amended and restated employment agreement with RobertMr. Liscouski, ourpursuant to which Mr. Liscouski serves as the Company’s Chief Executive Officer, on April 26, 2021 (the “Liscouski Employment Agreement”)Officer. The agreement provides for an initial term of three years and automatically renews for consecutive one-year terms at the end of the initial term, unless either party provides written notice to the other party of their intention not to renew at least 90 days prior to the end of the applicable term or Mr. Liscouski’s employment is terminated pursuant to the terms thereof. The agreement provides that Mr. Liscouski will receive an annual base salary of $400,000, subject to increase (but not decrease) by the Board or the Compensation Committee, and be eligible to earn an annual performance bonus of up to 50% of his annual base salary subject to the achievement of milestones established and approved by the Board (which the Company may waive). The agreement is for an indefinite term, subject to periodic review by the Board of Directors, stipulates a base salary (the “Base Salary”) of $400,000 per year. For the fiscal year ending December 31, 2021 and for subsequent fiscal years, the Liscouski Employment Agreement allows for an annual incentive bonus in the amount up to $150,000 per year, subject to Mr. Liscouski achieving certain performance based milestonesalso provides that are established by the Board of Directors. In connection with the Liscouski Employment Agreement, Mr. Liscouski was issued options for 250,000 restricted shares of the Company’s common stock in 2021.

As a full-time employee of the Company, Mr. Liscouski will be eligiblereceive annually 150,000 stock options to purchase shares of Common Stock at an exercise price of 110% of the fair market value of the Common Stock beginning on the first

15

Table of Contents

anniversary of the date of the agreement, which options vest over three years from date of its grant with one-third vesting on the date of grant and the remainder vesting in equal monthly installments thereafter. Pursuant to the terms of his employment agreement, Mr. Liscouski received (i) 250,000 stock options to purchase shares of Common Stock upon execution of the agreement and (ii) 250,000 stock options to purchase shares of Common Stock upon the listing of the Common Stock on Nasdaq. The agreement also provides that Mr. Liscouski is entitled to participate in such bonus programs and plans as the Company’s benefit programs.Company makes available from time to time.

Pursuant to Mr. Liscouski’s employment may beagreement, his employment is terminated byupon his death or disability, as described in the agreement, upon which all his unvested stock and option awards will immediately vest. In addition, the Company may terminate Mr. Liscouski’s employment under the agreement with or without “Cause”. “Cause” shall mean (i) conviction or entry of nolo contendere to any felony or a crime involving moral turpitude, fraud or embezzlement of Company property; (ii) dishonesty, gross negligence or gross misconduct that is materially injurious toCause, as defined in the Company or material failure to perform her/his duties under this Agreement which has not been cured byagreement, and Mr. Liscouski within 10 days after he shall have received written notice frommay terminate his employment under the Company stating with reasonable specificityagreement for or without Good Reason, as defined in the natureagreement. Upon termination of such failure to perform; and (iii) illegal use or use of drugs, alcohol, or other related substances that is materially injurious to the Company. If the Company terminates Mr. Liscouski’s employment without “Cause” the Company will continue paymentCause, or as a result of Mr. Liscouski’s Base Salaryresignation for an additional twelve (12) months from the dateGood Reason, then assuming Mr. Liscouski is terminated.

Severance Arrangements

Robert Liscouski is entitled to receive a severance payment, upon theLiscouski’s execution of a release in favor of the Company if terminated by us without cause. Thesubstantially in the form attached to his employment agreement, the Company is required to pay or provide to Mr. Liscouski severance benefits would include a payment in an amountpay equal to one year of such executive officer’s annualizedhis then current monthly base salary, compensation plus accrued paid time off. Additionally,and to continue his coverage under and the Company’s contributions towards his health care, dental, and life insurance benefits (unless, in each case, he would also be entitled to receive medical and dental insurance coverageis or becomes covered by an equivalent benefit), for one year following12 months from the date of termination. In addition, all stock options granted by the Company and then held by Mr. Liscouski will be accelerated and become fully vested and exercisable as of the date of his termination. If Mr. Liscouski resigns for Good Reason within 12 months after a Change of Control (as such term is defined in his employment agreement), then in addition to the above the Company will pay Mr. Liscouski an additional sum equal to 12 months of his then current monthly base salary. Finally, if Mr. Liscouski’s employment is terminated pursuant to his death, disability, or at his election, the Company will be obligated to pay him the pro rata portion of any bonus (to the extent earned prior to such termination) for the fiscal year in which his termination occurs.

The agreement also contains noncompetition, non-solicitation, and confidentiality provisions.

Mr.Christopher Roberts Employment Agreement

We entered into an employment agreement with Christopher Roberts our Chief Financial Officer, onas of April 26, 2021, (the “Roberts Employment Agreement”) wherebyin connection with Mr. Roberts is to provideservice as the Company with financial and accounting and business strategy services.Company’s Chief Financial Officer. The agreement is for an indefinitea term of three years, unless terminated earlier in accordance with its terms. The agreement provides that Mr. Roberts will receive a base salary of $12,500 twice per month (an annualized base salary of $300,000), subject to periodicannual review and adjustment as determined by the Board or the Compensation Committee, provided that his base salary cannot be decreased without his consent unless the compensation paid to all of Directors, stipulatesour executives is similarly reduced, and that he is eligible for an annual cash bonus of up to 50% of his base salary subject to his achieving certain performance-based milestones that are established and approved by the Board. Pursuant to his employment agreement, we issued Mr. Roberts options to purchase 400,000 restricted shares of Common Stock in 2021.

Mr. Roberts resigned for Good Reason effective June 30, 2023, and under the terms of his employment agreement the Company will pay or provide to Mr. Roberts severance pay equal to his then current monthly base salary for 12 months from the date of termination and will continue his coverage under and the Company’s contributions towards his health care, dental, and life insurance benefits (unless, in each case, he is or becomes covered by an equivalent benefit) for six months from the date of his termination, and all stock options granted by the Company and then held by Mr. Roberts were accelerated and became fully vested and exercisable as of that date. Mr. Roberts continues to support the Company as a consultant.

William J. McGann

We entered into an employment agreement with William J. McGann as of January 3, 2022, pursuant to which Mr. McGann serves as our Chief Operating Officer and Chief Technology Officer. Mr. McGann’s employment agreement is for a term of three years, unless terminated earlier in accordance with its terms of the agreement.

Mr. McGann’s employment agreement provides that he will receive a base salary (the “Base Salary”) of $300,000$16,666.67 twice per year. Formonth (an annualized base salary of $400,000), subject to annual review and adjustment as determined by the fiscal year ending December 31, 2021 and for subsequent fiscal years,Board or the Roberts Employment Agreement allows forCompensation Committee, provided that his base salary cannot be decreased without his consent unless the compensation paid to all of our executives is similarly reduced. The agreement also provides that Mr. McGann is eligible to receive an annual incentivecash bonus in an amount of up to 37.5% of his annualized base salary, subject to achieving certain performance milestones that are established and approved by the Board. Pursuant to his employment agreement,

1516

Table of Contents

the amountwe granted to Mr. McGann a stock option to purchase up to $150,000 per year, subject to Mr. Roberts achieving certain performance based milestones that are established by the Board of Directors. In connection with the Roberts Employment Agreement, Mr. Roberts was issued options for 400,000 restricted535,000 shares of Common Stock, which vest as follows: (i) 178,333 options vested immediately upon grant; (ii) 178,333 options vested on the Company’s common stock in 2021.

As a full12-time-month employeeanniversary of the Company,date of grant; and (iii) 178,334 options will vest on the 24-month anniversary of the date of grant. The agreement also provides that Mr. Roberts will be eligibleMcGann is entitled to participate in the Company’sany incentive programs and executive bonus and benefit programs.

Mr. Roberts’ employment may be terminated byprograms as the Company may establish from time to time.

Pursuant to Mr. McGann’s employment agreement, his employment is terminated upon his death or disability, as described in the agreement. In addition, the Company may terminate Mr. McGann’s employment under the agreement with or without “Cause”. “Cause” shall mean (i) convictionCause, as defined in the agreement, and Mr. McGann may terminate his employment under the agreement for or entrywithout Good Reason, as defined in the agreement. Upon termination of nolo contendere to any felony or a crime involving moral turpitude, fraud or embezzlement of Company property; (ii) dishonesty, gross negligence or gross misconduct that is materially injurious to the Company or material failure to perform her/his duties under this Agreement which has not been cured by Mr. Liscouski within 10 days after he shall have received written notice from the Company stating with reasonable specificity the nature of such failure to perform; and (iii) illegal use or use of drugs, alcohol, or other related substances that is materially injurious to the Company. If the Company terminates Mr. Roberts’sMcGann’s employment without “Cause” the Company will continue paymentCause, or as a result of Mr. Roberts’s Base SalaryMcGann’s resignation for an additional twelve (12) months from the dateGood Reason, then assuming Mr. Roberts is terminated.

Severance Arrangements

Mr. Roberts is entitled to receive a severance payment, upon theMcGann’s execution of a release in favor of the Company substantially in the form attached to his employment agreement, the Company is required pay or provide to Mr. McGann severance pay equal to his then current monthly base salary for 12 months from the date of termination and to continue his coverage under and the Company’s contributions towards his health care, dental, and life insurance benefits (unless, in each case, he is or becomes covered by an equivalent benefit) for six months from the date of his termination. In addition, all stock options granted by the Company and then held by Mr. McGann will be accelerated and become fully vested and exercisable as of the date of his termination. If Mr. McGann resigns for Good Reason or is terminated without Cause within 12 months after a Change of Control (as such term is defined in his employment agreement), then in addition to the above the Company will pay Mr. McGann an additional sum equal to 12 months of his then current monthly base salary. Finally, if Mr. McGann’s employment is terminated pursuant to his death, disability, or at his election, the Company will be obligated to pay him the pro rata portion of any bonus (to the extent earned prior to such termination) for the fiscal year in which his termination occurs.

The agreement also contains noncompetition, non-solicitation, and confidentiality provisions.

David Morris

We entered into an employment agreement with David Morris as of April 29, 2023, in connection with Mr. Morris’ service as our Chief Revenue Officer. Mr. Morris’s employment agreement is for a term of three years, unless terminated earlier in accordance with its terms.

Mr. Morris’ employment agreement provides that he will receive a base salary of $17,291.67 twice per month (an annualized base salary of $415,000), subject to annual review and adjustment as determined by usthe Board or the Compensation Committee, provided that his base salary cannot be decreased without cause.his consent unless the compensation paid to all of our executives is similarly reduced. The agreement also provides that Mr. Morris is eligible to receive an annual cash bonus and an annual grant of stock options subject to Mr. Morris achieving the performance milestones set forth in an exhibit to the agreement. Pursuant to his employment agreement, we also granted Mr. Morris options to purchase 200,000 shares of Common Stock that vests as follows: (i) 50,000 options vested on the first anniversary of the agreement; (ii) 50,000 vested on the second anniversary of the agreement; and (iii) 100,000 options will vest on the third anniversary of the agreement. The agreement also provides that Mr. Morris is entitled to participate in any incentive programs and bonus and benefit programs as the Company may establish from time to time.

On February 6, 2023, the Company eliminated the position of Chief Revenue Officer and terminated Mr. Morris’s employment. Pursuant to the terms of his employment agreement the Company paid to Mr. Morris severance pay equal to his then current monthly base salary and continued his coverage under and the Company’s contributions towards his health care, dental, and life insurance benefits would include a paymentfor six months after the date of his termination.

Dr. Yuping Huang

We entered into an employment agreement with Dr. Yuping Huang as of June 15, 2022, pursuant to which Mr. Huang serves as our Chief Quantum Officer. Dr. Huang’s employment agreement is for an initial term of three years unless terminated earlier in accordance with its terms.

Mr. Huang’s employment agreement provides that he will receive an annual base salary of $400,000, subject to annual review and adjustment as determined by the Board or the Compensation Committee, provided that his base salary cannot be decreased without his consent unless the compensation paid to all of our executives is similarly reduced. The agreement also provides that Dr. Huang is eligible to receive an annual cash bonus in an amount of up to 30.0% of his base salary subject to his achieving the performance milestones that are established and approved by the Board.

17

Table of Contents

Pursuant to his employment agreement, we granted to Dr. Huang options to purchase 400,000 shares of Common Stock, that vest as follows: (i) 100,000 options vested immediately upon grant; (ii) 100,000 options vested on the first anniversary of the date of grant; (iii) 100,000 options will vest on the second anniversary of the date of grant; and (iv) 100,000 options will vest on the third anniversary of the date of grant. The agreement also provides that Dr. Huang is entitled to participate in any incentive programs and executive bonus and benefit programs as the Company may establish from time to time.

Pursuant to Dr. Huang’s employment agreement, his employment is terminated upon his death or disability, as described in the agreement. In addition, the Company may terminate Dr. Huang’s employment under the agreement with or without Cause, as defined in the agreement, and Dr. Huang may terminate his employment under the agreement for or without Good Reason, as defined in the agreement. Upon termination of Dr. Huang’s employment without Cause, or as a result of Dr. Huang’s resignation for Good Reason, then assuming Dr. Huang’s execution of a release in favor of the Company substantially in the form attached to his employment agreement, the Company is required pay or provide to Dr. Huang severance pay equal to one year of such executive officer’s annualizedhis then current monthly base salary compensation plus accrued paid time off. Additionally,for 12 months from the date of termination and to continue his coverage under and the Company’s contributions towards his health care, dental, and life insurance benefits (unless, in each case, he would also be entitled to receive medical and dental insurance coverageis or becomes covered by an equivalent benefit) for six months followingfrom the date of his termination. In addition, all stock options granted by the Company and then held by Dr. Huang will be accelerated and become fully vested and exercisable as of the date of his termination. If Dr. Huang resigns for Good Reason or is terminated without Cause within 12 months after a Change of Control (as such term is defined in his employment agreement), then in addition to the above the Company will pay Dr. Huang an additional sum equal to 12 months of his then current monthly base salary.

The agreement also contains noncompetition, non-solicitation, and confidentiality provisions.

Outstanding Equity Awards at Fiscal Year End

The following table sets forth information regarding equity awards held by the Named Executive Officersnamed executive officers as of December 31, 2020:2022:

 

Option Awards(1)

 

Stock Awards

Name

 

Option Awards(1)

 

Number of
Securities
Underlying
Unexercised
Options,
Exercisable
(#)

 

Number of
Securities
Underlying
Unexercised
Options, Not
Exercisable
(#)

 

Option
Exercise
Price
($)

 

Option
Expiration
Date

 

Number
of Shares
or Units of
Stock That
Have Not
Vested
(#)

 

Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)

Number of
securities
underlying
unexercised
options
(#)
exercisable

 

Number of
securities
underlying
unexercised
options
(#)
unexercisable

 

Option
exercise
price
($)

 

Option
expiration
date

Robert Liscouski(1)

 

 

75,000

 

1.00

 

May 1, 2025

 

400,000

 

5,644,000

 

50,000

 

25,000

 

1.00

 

May 22 2025

Robert Liscouski

 

250,000

 

0

 

6.85

 

April 26, 2026

Robert Liscouski

 

83,325

 

166,675

 

2.40

 

January 24, 2027

Robert Liscouski

 

1,572,224

 

77,776

 

2.37

 

October 17, 2027

Christopher Roberts(2)

 

30,000

 

15,000

 

1.00

 

May 22, 2025

Christopher Roberts

   

45,000

 

1.00

 

May 1, 2025

 

400,000

 

5,644,000

 

233,333

 

166,667

 

6.85

 

April 26, 2026

Christopher Roberts

 

500,000

 

0

 

2.37

 

October 17, 2027

William J. McGann(3)

 

178,333

 

356,667

 

2.40

 

January 24, 2027

William J. McGann

 

1,000,000

 

0

 

2.37

 

October 17, 2027

David Morris(4)

 

50,000

 

150,000

 

6.70

 

April 29, 2026

David Morris

 

0

 

50,000

 

2.37

 

October 17, 2027

Dr. Yuping Huang(5)

 

100,000

 

300,000

 

2.37

 

October 12, 2027

____________

(1)      Mr. Liscouski’s stock options granted May 22, 2020 vest as follows: (i) 25,000 options vested on April 8, 2021, (ii) 25,000 options vested on April 8, 2022, and (iii) 25,000 options vested on April 8, 2023. Mr. Liscouski’s stock options granted April 26, 2021 vested as follows: (i) 250,000 options vested on the date of grant. Mr. Liscouski’s stock options granted January 24, 2022 vest as follows: (i) 83,333 options vested on July 15, 2022, (ii) 83,333 options vested on July 15, 2023, and (iii) 83,334 options vest on July 15, 2024. Mr. Liscouski’s stock options granted October 17, 2022 vest as follows: (i) 1,053,890 options vested on the date of grant, and (ii) 508,334 options vested on December 31, 2023 and the remainder vest in equal monthly increments of 2,778 shares through April 1, 2025, with the final month vesting 2,770 shares.

18

Table of Contents

(2)     Mr. Roberts’ stock options granted May 22, 2020 vest as follows: (i) 15,000 options vested on April 8, 2021, (ii) 15,000 options vested on April 8, 2022, and (iii) 15,000 options vested on April 8, 2023. Mr. Roberts’ stock options granted April 26, 2021 vest as follows: (i) 150,000 options vested on the date of grant, (ii) 83,333 options vested on April 26, 2022, (iii) 83,333 options vested on April 26, 2023, and 83,334 options vest on April 26, 2024. Mr. Roberts’ stock options granted October 17, 2022 vest as follows: (i) 350,000 options vested on the date of grant, and (ii) 150,000 options vested on December 31, 2023.

(3)      Mr. McGann’s stock options granted January 24, 2022 vest as follows: (i) 178,333 options vested on the date of grant, (ii) 178,333 options vested on January 24, 2023, and (iii) 178,334 options vest on January 24, 2024. Mr. McGann’s stock options granted October 17, 2022 vest as follows: (i) 750,000 options vested on the date of grant, and (ii) 250,000 options vested on December 31, 2023.

(4)      Mr. Morris’ stock options granted on April 29, 2021 vest as follows: (i) 50,000 options vested on April 5, 2022, (ii) 50,000 options vest on April 1, 2023, and (iii) 16,666 options vest on April 1, 2024. Mr. Morris’ stock options granted on October 17, 2022 vest as follows: (i) 16,667 options vest on March 1, 2023, (ii) 16,667 options vest on March 1, 2024, and (iii) 16,666 options vest on June 16, 2024. Mr. Morris is no longer employed by the Company so all vested and unvested options have been forfeited.

(5)      Dr. Huang’s stock options granted on October 12, 2022 vest as follows: (i) 100,000 options vested on the grant date, (ii) 100,000 options vested on June 16, 2023, (iii) 100,000 options vest on June 16, 2024, and (iv) 100,000 options vest on June 16, 2025.

Director Compensation

The Company’s independent directors did not receiveeach received cash compensation of $13,000 per quarter for their services as directors in fiscal year 2020. Beginning2022.

The following table presents the total compensation earned and paid to non-employee members of the Board for the fiscal year ended December 31, 2022. In addition to the compensation outlined below, we reimburse non-employee Directors for reasonable travel expenses and out-of-pocket costs incurred in 2021, Directors will receive cashattending meetings of the Board or events that they attend on behalf of the Company.

Name

 

Fees Earned or
Paid in Cash
($)

 

Stock
Awards
($)

 

Stock
Options
($)

 

Total
($)

Bertrand Velge

 

52,000

 

 

829,500

 

881,500

Michael Turmelle

 

52,000

 

 

829,500

 

881,500

Carl Weimer(1)

 

 

 

 

Robert Fagenson

 

52,000

 

 

829,500

 

881,500

____________

(1)      Mr. Weimer was appointed to the Company’s Board on January 4, 2023.

Pay versus Performance Table

The following table shows the total compensation of $5,000 per quarter for their service.the named executive officers as set forth in the Summary Compensation Table, the compensation “actually paid” (“CAP”) to the NEOs, the Company’s total shareholder return (“TSR”), and our net income for the years ended December 31, 2022 and 2021.

2022 Pay vs. Performance Table

Fiscal Year

 

Summary
compensation
table total for
PEO(1)

 

Compensation
actually paid
to PEO(1)(3)

 

Average
summary
compensation
table total for
non-PEO
NEOs(2)

 

Average
compensation
actually paid
to non-PEO
NEOs(2)(3)

 

Value of
initial fixed
$100
investment
based on
total
shareholder
return

 

Net income
(loss)

2022

 

$

5,093,339

 

$

4,190,690

 

$

1,842,251

 

$

1,543,905

 

$

11

 

$

(38,593,700

)

2021

 

$

2,264,400

 

$

1,461,900

 

$

2,279,058

 

$

938,308

 

$

24

 

$

(27,898,847

)

____________

(1)      In the table above, our PEO is Robert Liscouski

(2)      The non-PEO NEOs for each applicable year are as follows:

– 2022: Christopher Roberts, Yuping Huang, William McGann, and David Morris

– 2021: Christopher Roberts and David Morris

1619

Table of Contents

(3)      The SEC rules require that certain adjustments be made to the Summary Compensation Table (“SCT”) totals to determine CAP, as reported in the Pay versus Performance table above. The following table details the applicable adjustments that were made to determine CAP:

Year

 

Executives

 

SCT
total
($)

 

Deduct
grant
date fair
value of
stock
awards & option
awards
($)

 

Add
year-end
fair
value of
unvested
equity
granted
in the
year
($)

 

Add
year-over-
year
change
in fair
value of
outstanding
and
unvested
equity
granted
in prior
years
($)

 

Add
fair value
as of
vesting
date of
equity
awards
granted
and
vested
in the
year
($)

 

Add
year-
over-year
change
in fair
value of
equity
awards
granted
in prior
years
that
vested
in the
year
($)

 

Deduct
fair
value
at the
end of the prior year of equity awards that failed to meet vesting conditions in the year ($)

2022

 

PEO

 

5,093,339

 

(4,510,500

)

 

369,121

 

(47,496

)

 

3,333,726

 

(47,500

)

 

  

Non-PEO NEOs (average)

 

1,842,251

 

(1,476,375

)

 

266,767

 

(78,375

)

 

1,020,512

 

(30,875

)

 

2021

 

PEO

 

2,264,400

 

(1,712,500

)

 

 

(535,000

)

 

1,712,500

 

(267,500

)

 

  

Non-PEO NEOs (average)

 

2,279,058

 

(2,040,000

)

 

426,250

 

(160,500

)

 

513,750

 

(80,250

)

 

Relationship Between Compensation Actually Paid and Performance Measures

The Pay versus Performance table above and the charts below illustrate the following:

CAP to our PEO and non-PEO NEOs has not moved in line with our TSR, that is, declines in our TSR over 2021 and 2022 were not accompanied by declining compensation outcomes during those years. The CAP definition of pay reflects changes in the value of unvested and vested equity, so declines in the value of our stock price were similarly reflected in the value of equity (both unvested and vested) as compared to grant-date SCT values of pay. The declines in the value of our stock price were, however, reflected in the difference between compensation is reflected in the SCT and CAP for the PEO and non-PEO NEOs in both 2022 and 2021. In both 2022 and 2021, the value of outstanding equity held by our PEO and non-PEO NEOs declined and resulted in a negative impact on CAP for both our PEO and the non-PEO NEOs. Total CAP for our PEO and non-PEO NEOs did increase somewhat in 2022 compared to 2021, due to equity grants related to the QPhoton merger. We expect that as the market value of the Common Stock increases, CAP values would also increase given both the equity tie to stock price and the potential impact of positive financial results on incentive payouts.

CAP does not move in line with our net income, as the measure can be volatile year-over-year due to accounting requirements, such as the inclusion of estimated values of equity grants, changes in the value of inventories, acquisitions, and intangible asset amortization, and related metrics. As such, we use other key measures of financial performance for a growing company, such as revenue, bookings, and EBITDA margin, in our incentive programs.

Reference Charts

20

Table of Contents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information as of September 20, 2021the Record Date concerning the beneficial ownership of common stock for:the Common Stock for (i) each director and director nominee, (ii) each Named Executive Officer in the Summary Compensation Table under “Executive Compensation” above,named executive officer, and (iii) all executive officers and directors as a group, and (iv) eachgroup. We do not believe that any person (including any “group” as that term is used in Section 13(d)(3) of the Exchange Act) known by us to be, other than Dr. Huang, is the beneficial owner of 5% or more of our common stock.the outstanding shares of Common Stock. The address for each of the persons below who are beneficial owners of 5% or more of our common stockDr. Huang is our corporate address at 215 Depot Court SE, Suite 215, Leesburg, VA 20175.

Beneficial ownership has been determined in accordance with the rules of the SEC and is calculated based on 29,156,81575,094,943 shares of our common stockCommon Stock issued and outstanding as of September 20, 2021.on the Record Date. Shares of common stockCommon Stock subject to options, warrants, preferred stock or other securities convertible into common stockor pursuant to which the holder has the right to acquire Common Stock that are currently exercisable or convertible, or that are exercisable or convertible within 60 days of September 20, 2021,the Record Date, are deemed outstanding for computing the percentage of the person holding the option, warrant, preferred stock, or convertibleother such security but are not deemed outstanding for computing the percentage of any other person.

Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table below have sole voting and investment power with respect to all shares of common stock that they beneficially own.

The following table sets forth, as of September 20, 2021, the number of shares of common stock owned of record and beneficially by our executive officers, directors and persons who hold 5% or more of the outstanding shares of common stock of the Company.

The amounts and percentages of our common stock beneficially owned are reported on the basis of SEC rules governing the determination of beneficial ownership of securities. Under the SEC rules, a person is deemed to be a “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the voting of such security, or “investment power,” which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has the right to acquire beneficial ownership within 60 days through the exercise of any stock option, warrant or other right. Under these rules, more than one person may be deemed a beneficial owner of the same securities and a person may be deemed to be a beneficial owner of securities as to which such person has no economic interest. Unless otherwise

Except as indicated each ofby the shareholdersfootnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table below or his or her family members, hashave sole voting and investment power with respect to such shares of our common stock. Except as otherwise indicated, the address of each of the shareholders listed below is: c/o Quantum Computing Inc., 215 Depot Court SE, Suite 215, Leesburg, VA 20175.

Applicable percentage ownership is based on 29,156,815 shares of Common Stock outstanding as of September 20, 2021. In computing the number of shares of Common Stock beneficially owned by a person and the percentage ownership of that person, we deemed to be outstanding all shares of Common Stock as held by that person or entity that are currently exercisable or that will become exercisable within 60 days of September 20, 2021.they beneficially own.

17

Table of Contents

Name and Address of Beneficial Owner

 

Common
Stock Owned
Beneficially

 

Percent of
Class

Named Executive Officers and Directors

    

Robert Liscouski, Chief Executive Officer and Chairman(1)

 

1,012,500

 

3.47

Christopher Roberts, Chief Financial Officer(2)

 

725,000

 

2.49

Bertrand Velge(3)

 

2,167,888

 

7.44

Justin Schreiber(4)

 

1,250,000

 

4.29

Robert Fagenson(5)

 

100,000

 

0.34

All directors and officers as a group (5 persons)

 

5,255,388

 

17.68

5% or greater shareholders

    

None

 

 

 

 

     

Total

 

5,255,388

 

17.68

Name and Address of Beneficial Owner

 

Common Stock
Owned

Beneficially

 

Percent of
Class

Named Executive Officers and Directors

    

Robert Liscouski, Chief Executive Officer and Chairman(1)

 

2,997,169

 

3.88

Chris Boehmler, Chief Financial Officer(2)

 

93,644

 

0.12

William J. McGann(3)

 

1,518,766

 

1.99

Bertrand Velge(4)

 

2,567,888

 

3.40

Robert Fagenson(5)

 

566,670

 

0.75

Michael Turmelle(6)

 

400,000

 

0.53

Dr. Yuping Huang(7)

 

24,136,906

 

32.06

Dr. Carl Weimer(8)

 

50,000

 

0.07

All directors and officers as a group (8 persons)

 

32,331,039

 

40.37

Other 5% shareholders

 

 

0.00

Total

 

32,331,039

 

40.37

____________

*        Less than 1%

(1)      Includes 1,012,500Consists of 911,055 shares of common stock.Common Stock and options to purchase 2,086,114 shares of Common Stock.

(2)      Includes 725,000Consists of 60,310 shares of common stock.Common Stock and options to purchase 33,334 shares of Common Stock.

(3)      IncludesConsists of 162,100 shares of Common Stock and options to purchase 1,356,666 shares of Common Stock.

(4)      Consists of 2,167,888 shares of common stock.

(4)      Mr. Schreiber has votingCommon Stock and investment control of the following shares: 1,250,000options to purchase 400,000 shares of common stockCommon Stock.

(5)      Consists of 100,000 shares of Common Stock held by JOJ Holdings,Fagenson Fixed Income Partners, LLC. Mr. SchreiberFagenson has effective control over this entity through several family trusts and indirect ownership through another private corporation he controls, and is the President of JOJ Holdings, LLC and isdeemed to be the beneficial owner of these securities. Mr. Schreiber resigned from the Board on September 22, 2021.

(5)      Includes 100,000shares, and options to purchase 466,670 shares of common stockCommon Stock.

(6)      Consists of options to purchase 400,000 shares of Common Stock.

(7)      Consists of 23,936,906 shares of Common Stock and options for 100,000to purchase 200,000 shares of common stock.Common Stock. Does not include any shares of Common Stock relating to unvested warrants received by Dr. Huang as QPhoton merger consideration that may vest upon the exercise of options and warrants issued and outstanding on June 16, 2022, at the closing date of the QPhoton merger.

(8)      Consists of options to purchase 50,000 shares of Common Stock.

1821

Table of Contents

TRANSACTIONS WITH RELATED PERSONS

The following is a summary of transactions since January 1, 2018 to which weThere have been no transactions involving the Company since the beginning of its last fiscal year, or will be a partyany currently proposed transactions, in which the Company was or is to be a participant and the amount involved exceeded or will exceed $ (one percent of the average of our total assets at year-end for our last two completed fiscal years)exceeds $120,000 and in which any of our directors, executive officers or beneficial holders of more than 5% of any class of our capital stock, or any immediate family member of, or person sharing a household with, any of these individuals, had or will have a direct or indirect material interest, other than compensation arrangements that are described under the section captioned “Executive compensation.Executive Compensation.

Other than as disclosed below, there have been no transactions involving the Company since the beginning of the last fiscal year, or any currently proposed transactions, in which the Company was or is to be a participant and the amount involved exceeds $120,000 or one percent of the average of the Company’s total assets at year-end for the last two completed fiscal years, and in which any related person had or will have a direct or indirect material interest.

To finance the acquisition of the control block of shares in IBGH, an investor group (the “Initial Investors.”), loaned Convergent Risk Group, LLC (Convergent) $275,000, in exchange for Promissory Notes from Convergent (the “Promissory Notes”) in the total amount of $275,000. Convergent, a Virginia limited liability company, is owned 100% by Mr. Robert Liscouski, who is the CEO and currently the majority shareholder of the Company. To induce Mr. Liscouski to serve as CEO of the Company, the Company assumed the “Promissory Notes” in the total amount of $275,000 and certain liabilities (the “Liabilities”). The Liabilities and the Promissory Notes are collectively the “Convergent Liabilities.” The Convergent Liabilities assumed by the Company were exchanged for Convertible Promissory Notes issued by the Company for $275,000 (the same amount that Convergent had issued them for). The Convertible Promissory Notes were convertible into common stock of the Company at a conversion price of $0.10 per share. As of December 31, 2020 all of the Convertible Promissory Notes had been converted to common stock.

To provide the Company with advertising and marketing services, the Company contracted with JLS Ventures LLC (“JLS”), an entity wholly owned by Justin Schreiber, a former member of the Company’s board of directors, to procure and manage advertising services. The agreement with JLS is for a period of one year and is terminable upon thirty days’ notice. During the year ending December 31, 2021, the Company reimbursed JLS $140,698 for costs associated with advertisement procurement.

1922

Table of Contents

AUDIT-RELATED MATTERS

Audit Committee Report

The Audit Committee of the Board of Directors is comprised of independent directors and operates under a written charter adopted by the Board of Directors.Board. The Audit Committee Chartercharter is reviewed and updated as needed per applicable rules of the SEC and The Nasdaq Stock Market.Nasdaq.

The Audit Committee serves in an oversight capacity. Management is responsible for the Company’s internal controlscontrol over financial reporting. The independent auditors are responsible for performing an independent audit of the Company’s financial statements per the standards of the Public Company Accounting Oversight Board (“PCAOB”) and issuing a report thereon. The Audit Committee’s primary responsibility is to monitor and oversee these processes and to select and retain the Company’s independent auditors. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management the Company’s audited financial statements and discussedincluding not only the acceptability but also the quality of the accounting principles, the reasonableness of the significant judgments and estimates, critical accounting policies, and the clarity of disclosures in the audited financial statements prior to issuance.

The Audit Committee reviewed and discussed the audited financial statements as of and for the year ended December 31, 2020,2022, with the Company’s independent auditors, BF Borgers CPA P.C. LLP (“Borgers”), and discussed not only the acceptability but also the quality of the accounting principles, the reasonableness of the significant judgments and estimates, critical accounting policies and the clarity of disclosures in the audited financial statements prior to issuance. The Audit Committee discussed with Borgers the matters required to be discussed by the applicable requirements of the PCAOB and the SEC.PCAOB. The Audit Committee has received the written disclosures and the letter from Borgers required by the applicable requirements of the PCAOB regarding the independent auditorauditor’s communications with the Audit Committee concerning independence and has discussed with Borgers.Borgers its independence.

Based on thesuch review and discussions, with our independent registered public accounting firm, Borgers, the Audit Committee has recommended to the Board, of Directors, and the Board has approved, that the audited financial statements be included in ourthe Company’s Annual Report on Form 10-K for the year ended December 31, 2020,2022, for filing with the SEC.

MEMBERS OF THE AUDIT COMMITTEE:

Robert Fagenson — Chairman of the Committee

William J. McGannMichael Turmelle

Bertrand Velge

2023

Table of Contents

PRINCIPAL ACCOUNTING FEES AND SERVICES

BF Borgers CPA PC served as our independent registered public accountants for the years ended December 31, 20192021 and 2020.2022.

Audit Fees

For the Company’s fiscal years ended December 31, 20202022 and 2019,2021, we were billed approximately $43,200an aggregate of $119,800 and $57,100,$46,800, respectively, for professional services rendered by our independent auditors for the audit and review of our financial statements.

Tax Fees

For the Company’s fiscal years ended December 31, 20202022 and 2019,2021, there were no fees$9,020 and $1,900 for professional services rendered by our independent auditors for tax compliance, tax advice, and tax planning.

All Other Fees

For the Company’s fiscal yearsyear ended December 31, 2020 and 2019,2022, we were billed approximately $5,400 and $20,000, respectively,an aggregate of $49,500 for professional services rendered by our independent auditors related to the Registration Statement on Form 10S-12-1(g) and Form S-3 and amendments thereto that the Company filed with the SEC in those years.that year. Borgers did not provide other services to us, other than audit and tax services, during the year ended December 31, 2021.

Pre-Approval Policies

AllThe Audit Committee has procedures to pre-approve the engagement of the above services and fees were reviewed and approved by the entire Board. No services were performed beforeour independent auditors to provide audit services; there is no pre-approval policy or without approval.procedures with respect to non-audit services.

2124

Table of Contents

MATTERS TO BE VOTED ON

PROPOSAL NO. 1: ELECTION OF DIRECTORS

The Company’s Board of Directors is currently comprised of fivesix directors. A total of fivesix directors will be elected at the Annual Meeting to serve until the next annual meeting of shareholdersstockholders to be held in 2022, or2024 and until their successors are duly elected and qualified. OfThe terms of all of the Board members whose term expirescurrently in office expire at the Annual Meeting, Robert Liscouski, Christopher Roberts, Bertrand Velge, William J. McGann and Robert Fagensonthey have each been nominated by the Board for re-election at the Annual Meeting and are all standing for reelection.re-election. The personsperson named as “Proxies” in the enclosed Proxy“proxy” will vote the shares represented by all valid returnedvalidly submitted proxies in accordance with the specifications of the shareholders returningstockholders submitting such proxies. If no choice has been specified by a shareholder,stockholder, the shares will be voted FOR the election of each of the Board’s nominees. If at the time of the Annual Meeting any of the nominees named below should be unable or unwilling to serve, which event is not expected to occur, the discretionary authority provided in the Proxyproxy will be exercised to vote for such substitute nominee or nominees, if any, as shall be designated by the Board of Directors.Board. If a quorum is present, and voting, the nominees for directors receiving the highest number of FOR votes will be elected. Abstentions and broker non-votes will have no effect on the vote.

NOMINEES FOR ELECTION AS DIRECTOR

Nominees

The persons nominated as directors are as follows:

Name

 

Age

 

Position(s)

Robert Liscouski

 

6769

 

Chairman of the Board of Directors, President, and Chief Executive Officer (Principal Executive Officer)

Christopher RobertsDr. Yuping Huang

 

6744

 

Chief FinancialQuantum Officer, (Principal Financial Officer) (Principal Accounting Officer), Director

Bertrand VelgeDr. Carl Weimer

 

6261

 

Director

William J. McGannBertrand Velge

 

63

 

Director

Robert Fagenson

 

7374

Director

Michael Turmelle

64

 

Director

Vote Required

Votes may be cast: “FOR ALL” nominees, “WITHHOLD ALL” nominees or “FOR ALL EXCEPT” those nominees noted by you on the appropriate portion of your proxy or voting instruction card. The fivesix nominees for director receiving the highest number of votes “FOR” their election will be elected as directors. This is called a plurality. WithholdingElecting to “WITHOLD” authority on the vote of a vote from a director nomineenominee’s election will result in such share(s) not bebeing voted with respect toin favor of the director nominee indicatednominee’s election and will have no impact on the outcome on the election of directors, although itshares that “WITHHOLD” authority with respect to the election of any directors will be counted for the purposes of determining whether there is a quorum. Broker non-votes will have no effect on the outcome of this proposal.the election for directors.

Recommendation of ourthe Board

OurTHE Board unanimously recommends that you vote “FOR” the election of each of the BOARD’S nominees for directors.ELECTION AS directors SET FORTH ABOVE.

22

Table of Contents

PROPOSAL NO. 2: APPROVAL OF AN AMENDMENT TO THE 2019 PLAN

On July 22, 2021, the Board approved, subject to stockholder approval, an amendment to the 2019 Plan to increase the maximum number of shares of common stock available for issuance under the 2019 Plan by an additional 1,500,000 shares.

Currently, the maximum number of shares of common stock available for issuance under the 2019 Plan is 1,500,000.

As of September 20, 2021, there are 0 shares of common stock available for future award grants under the 2019 Plan. As of such date, there were (i) options to purchase an aggregate of 1,500,000 shares of common stock outstanding under the 2019 Plan at a weighted-average exercise price of $3.98 per share, and (ii) 0 shares of unvested restricted common stock outstanding under the 2019 Plan. Between the dates whereby the 2019 Plan has become effective, November 14, 2019 and September 20, 2021, 30,000 shares of common stock have become issued and outstanding as a result of vested awards under the 2019 Plan.

The Company faces intense competition in recruiting high quality personnel, and in retaining our employees. The Board continues to believe that stock-based incentives are important factors in attracting, retaining and awarding officers, employees, directors and consultants and closely aligning their interests with those of our stockholders.

As of September 20, 2021, 29,156,815 shares of the Company’s common stock are issued and outstanding. The Company faces intense competition in recruiting high quality personnel, and in retaining our employees. The Board continues to believe that stock-based incentives are important factors in attracting, retaining and awarding officers, employees, directors and consultants and closely aligning their interests with those of our stockholders.

The Board believes that increasing the number of shares available for issuance under the 2019 Plan by 1,500,000 shares, which will be effected by increasing the Baseline Amount from 1,500,000 shares to 3,000,000 shares, is consistent with the Company’s compensation philosophy (and with responsible compensation policies generally) and will preserve the Company’s ability to attract and retain capable officers, employees, directors and consultants. The Company does not have any shares available under the 2019 Plan. The Board believes it is imperative in view of our compensation structure and strategy and that the availability of the additional shares will help the Company to have a more sufficient number of shares of common stock authorized for issuance under the 2019 Plan. The Board adopted this amendment to ensure that, as we grow over the coming year, we can operate effectively in our recruitment efforts, and create incentives for the retention of employees and other service providers, by granting the equity arrangements available under the 2019 Plan to employees, directors, and key consultants at levels determined appropriate by the Compensation Committee. In addition to our five directors (which include our Chief Executive Officer and Chief Financial Officer), approximately 26 employees and approximately 10 key consultants are eligible to participate in the 2019 Plan.

Summary of 2019 Plan, as Proposed to be Amended

The following is a summary of the material terms and conditions of the 2019 Plan, as proposed to be amended, and is qualified in its entirety by the provisions contained in the 2019 Plan, as amended (the “Amended 2019 Plan”), a copy of which is attached to this Proxy Statement as Annex A:

Common Stock Reserved for Issuance under the 2019 Plan.    As amended, the maximum number of shares of common stock available for issuance under the 2019 Plan will be 3,000,000.

Currently the maximum number of shares of common stock available for issuance under the 2019 Plan is 1,500,000. As a result, the effect of the proposed amendment to the 2019 Plan will be to increase the shares available for issuance under 2019 Plan from 1,500,000 shares to 3,000,000 shares.

Plan Highlights

Options are subject to the following conditions:

(i)     The Committee (as defined below) determines the exercise price of Incentive Options at the time the Incentive Options are granted. The assigned exercise price must be no less than 100% of the Fair Market Value (as defined in the 2019 Plan) of the Company’s Common Stock. In the event that the recipient is a Ten Percent Owner (as defined in the 2019 Plan), the exercise price must be no less than 110% of the Fair Market Value of the Company.

23

Table of Contents

(ii)    The exercise price of each Non-qualified Option will be at least 100% of the Fair Market Value of such share of the Company’s Common Stock on the date the Non-qualified Option is granted, unless the Committee, in its sole and absolute discretion, elects to set the exercise price of such Non-qualified Option below Fair Market Value.

(iii)   The Committee fixes the term of Options, provided that Options may not be exercisable more than ten years from the date the Option is granted, and provided further that Incentive Options granted to a Ten Percent Owner may not be exercisable more than five years from the date the Incentive Option is granted.

(iv)   Stock Options shall become exercisable and/or vested at such time or times, whether or not in installments, as shall be determined by the Committee at or after the Grant Date. The Award Agreement may permit a grantee to exercise all or a portion of a Stock Option immediately at grant; provided that the Shares issued upon such exercise shall be subject to restrictions and a vesting schedule identical to the vesting schedule of the related Stock Option, such Shares shall be deemed to be Restricted Stock for purposes of the Plan, and the optionee may be required to enter into an additional or new Award Agreement as a condition to exercise of such Stock Option. An optionee shall have the rights of a stockholder only as to Shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options. An optionee shall not be deemed to have acquired any Shares unless and until a Stock Option shall have been exercised pursuant to the terms of the Award Agreement and this Plan and the optionee’s name has been entered on the books of the Company as a stockholder.

(v)    The Committee may designate the vesting period of Options. In the event that the Committee does not designate a vesting period for Options, the Options will vest in equal amounts on each fiscal quarter of the Company through the five (5) year anniversary of the date on which the Options were granted. The vesting period accelerates upon the consummation of a Sale Event (as defined in the 2019 Plan).

(vi)   Options are not transferable except to a recipient’s family members or partnerships in which such family members are the only partners and Options are exercisable only by the Options’ recipient, except upon the recipient’s death.

(vii)  Incentive Options may not be issued in an amount or manner where the amount of Incentive Options exercisable in one year entitles the holder to Common Stock of the Company with an aggregate Fair Market value of greater than $100,000.

Awards of Restricted Stock are subject to the following conditions:

(i)     The Committee grants Restricted Stock Options and determines the restrictions on each Restricted Stock Award (as defined in the 2019 Plan). Upon the grant of a Restricted Stock Award and the payment of any applicable purchase price, grantee is considered the record owner of the Restricted Stock and entitled to vote the Restricted Stock if such Restricted Stock is entitled to voting rights.

(ii)    Restricted Stock may not be delivered to the grantee until the Restricted Stock has vested.

(iii)   Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as provided in the 2019 Plan or in the Award Agreement (as defined in the 2019 Plan).

Upon a Termination Event (as defined in the 2019 Plan), the Company or its assigns shall have the right and option to repurchase from a Holder of Shares (as defined in the 2019 Plan) received pursuant to a Restricted Stock Award any Shares that are still subject to a risk of forfeiture as of the Termination Event (as defined in the 2019 Plan).

Purpose

The objective of the 2019 Plan is to encourage and enable the officers, employees, directors, consultants and other key persons of the Company and its subsidiaries, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.

24

Table of Contents

Grants

The 2019 Plan permits the granting of incentive stock options, nonqualified stock options, stock awards, restricted stock units, stock appreciation rights (“SARs”) and other equity-based awards (collectively, “grants”). Although all employees and all of the employees of our subsidiaries are eligible to receive grants under our Plan, the grant to any particular employee is subject to the discretion of the Board, or at the discretion of the Board, or by a committee of the Board, comprised of not less than two directors (such body that administers the 2019 Plan, the “Committee”).

The maximum number of shares of our Common Stock that we may issue under the 2019 Plan may not exceed 1,500,000, and no more than 250,000 may be granted as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). If a grant expires or terminates for any reason before it is fully vested or exercised, or if any grant is forfeited, we may again make the number of shares subject to that grant that the participant has not purchased or that has not vested subject to another grant under the 2019 Plan.

We have made and will make appropriate adjustments to outstanding grants and to the number or kind of shares subject to the 2019 Plan in the event of a stock split, reverse stock split, stock dividend, share combination or reclassification and certain other types of corporate transactions, including a merger or a sale of all or substantially all of our assets.

All grants will be determined by the Board or a committee of the Board (the “Committee”) and at this time, 1,500,000 stock option grants have been determined and awarded.

Administration

The 2019 Plan shall be administered by the Compensation Committee of the Board, comprised of not less than three directors or the Board of Directors in the absence of a Compensation Committee of the Board. All references herein to the “Committee” shall be deemed to refer to the group then responsible for administration of the 2019 Plan at the relevant time (i.e., either the Board of Directors or a committee or committees of the Board, as applicable).

(i)     to select the individuals to whom Awards may from time to time be granted;

(ii)    to determine the time or times of grant, and the amount, if any, of Incentive Stock Options, Non-Qualified Stock Options, SARs, Restricted Stock Awards, Unrestricted Stock Awards, Restricted Stock Units, or any combination of the foregoing, granted to any one or more grantees;

(iii)   to determine the number and types of Shares to be covered by any Award and, subject to the provisions of the 2019 Plan, the price, exercise price, conversion ratio or other price relating thereto;

(iv)   to determine and, subject to the 2019 Plan, to modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the 2019 Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the form of Award Agreements;

(v)    to accelerate at any time the exercisability or vesting of all or any portion of any Award;

(vi)   to impose any limitations on Awards, including limitations on transfers, repurchase provisions and the like, and to exercise repurchase rights or obligations;

(vii)  subject to any restrictions imposed under the 2019 Plan or by Section 409A, to extend at any time the period in which Stock Options may be exercised; and

(viii) at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the 2019 Plan and for its own acts and proceedings as it shall deem advisable; to interpret the terms and provisions of the 2019 Plan and any Award (including Award Agreements); to make all determinations it deems advisable for the administration of the 2019 Plan; to decide all disputes arising in connection with the 2019 Plan; and to otherwise supervise the administration of the 2019 Plan.

All decisions and interpretations of the Committee shall be binding on all persons, including the Company and all Holders.

25

Table of Contents

Grant Instruments

All grants will be subject to the terms and conditions set forth in our Plan and to such other terms and conditions consistent with our Plan as the Committee deems appropriate and as are specified in writing by the Committee to the individual in a grant instrument or an amendment to the grant instrument. All grants will be made conditional upon the acknowledgement of the grantee in writing or by acceptance of the grant, that all decisions and determinations of the Compensation Committee will be final and binding on the grantee, his or her beneficiaries and any other person having or claiming an interest under such grant.

Terms and Conditions of Grants

The grant instrument will state the number of shares subject to the grant and the other terms and conditions of the grant, consistent with the requirements of our Plan. The purchase price per share subject to an option (or the exercise price per share in the case of a SAR) must equal at least the fair market value of a share of the Company’s common stock on the date of grant. The exercise price per share for the Shares covered by a Stock Option shall be determined by the Committee at the time of grant but shall not be less than 100%of the Fair Market Value on the Grant Date. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the exercise price per share for the Shares covered by such Incentive Stock Option shall not be less than 110% of the Fair Market Value on the Grant Date.

Under the 2019 Plan, the term “Fair Market Value” of the Stock on any given date means the fair market value of the Stock determined in good faith by the Committee based on the reasonable application of a reasonable valuation method that is consistent with Section 409A of the Code. If the Stock is admitted to trade on a national securities exchange, the determination shall be made by reference to the closing price reported on such exchange. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date for which there is a closing price. If the date for which Fair Market Value is determined is the first day when trading prices for the Stock are reported on a national securities exchange, the Fair Market Value shall be the “Price to the Public” (or equivalent).

“Ten Percent Owner” means an employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10 percent of the combined voting power of all classes of stock of the Company or any parent of the Company or any Subsidiary.

Transferability

Restricted Stock, Stock Options, SARs and, prior to exercise, the Shares issuable upon exercise of such Stock Option, shall not be transferable by the optionee otherwise than by will, or by the laws of descent and distribution, and all Stock Options shall be exercisable, during the optionee’s lifetime, only by the optionee, or by the optionee’s legal representative or guardian in the event of the optionee’s incapacity. Notwithstanding the foregoing, the Committee, in its sole discretion, may provide in the Award Agreement regarding a given Stock Option or Restricted Stock award that the optionee may transfer by gift, without consideration for the transfer, his or her Non-Qualified Stock Options to his or her family members (as defined in Rule 701 of the Securities Act), to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners (to the extent such trusts or partnerships are considered “family members” for purposes of Rule 701 of the Securities Act), provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award Agreement, including the execution of a stock power upon the issuance of Shares.

Amendment and Termination

The Board may, at any time, amend or discontinue the 2019 Plan and the Committee may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall adversely affect rights under any outstanding Award without the consent of the holder of the Award. The Committee may exercise its discretion to reduce the exercise price of outstanding Stock Options or effect repricing through cancellation of outstanding Stock Options and by granting such holders new Awards in replacement of the cancelled Stock Options. To the extent determined by the Committee to be required either by the Code to ensure that Incentive Stock Options granted under the 2019 Plan are qualified under Section 422 of the Code or otherwise, Plan amendments shall be subject to approval by the Company stockholders entitled to vote at a meeting of stockholders. Nothing in this Section 12 shall limit the Board’s or Committee’s authority to take any action permitted pursuant to

26

Table of Contents

Section 3(c). The Board reserves the right to amend the 2019 Plan and/or the terms of any outstanding Stock Options to the extent reasonably necessary to comply with the requirements of the exemption pursuant to Rule 12h-1 of the Exchange Act.

Federal Income Tax Consequences

The following summary is intended only as a general guide as to the United States federal income tax consequences under current law of participation in our Plan and does not attempt to describe all possible federal or other tax consequences of such participation or tax consequences based on particular circumstances.

Stock option grants under the 2019 Plan may be intended to qualify as incentive stock options under Internal Revenue Code of 1986, as amended (“IRC”) §422 or may be non-qualified stock options governed by IRC §83. Generally, no federal income tax is payable by a participant upon the grant of a stock option and no deduction is taken by the Company. Under current tax laws, if a participant exercises a non-qualified stock option, he or she will have taxable income equal to the difference between the market price of the stock on the exercise date and the stock option grant price. The Company will be entitled to a corresponding deduction on its income tax return. A participant will have no taxable income upon exercising an incentive stock option if the shares received are held for the applicable holding periods (except that alternative minimum tax may apply), and the Company will receive no deduction when an incentive stock option is exercised. The Company may be entitled to a deduction in the case of a disposition of shares acquired under an incentive stock option that occurs before the applicable holding periods have been satisfied.

Restricted stock and restricted stock units are also governed by IRC §83. Generally, no taxes are due when the award is made. Restricted stock generally becomes taxable when it is no longer subject to a “substantial risk of forfeiture” (i.e., becomes vested or transferable). Restricted stock units become taxable when settled. When taxable to the participant, income tax is paid on the value of the stock or units at ordinary rates. The Company will generally be entitled to a corresponding deduction on its income tax return. Any additional gain on shares received are then taxed at capital gains rates when the shares are sold.

The grant of a stock appreciation right will not result in income for the participant or in a tax deduction for the Company. Upon the settlement of such a right, the participant will recognize ordinary income equal to the aggregate value of the payment received, and the Company generally will be entitled to a tax deduction in the same amount.

The foregoing is only a summary of the effect of federal income taxation on the participant and the Company under the 2019 Plan. It does not purport to be complete and does not discuss the tax consequences arising in the context of a participant’s death or the income tax laws of any municipality, state or foreign country in which the participant’s income may be taxable.

Tax Withholding

Each grantee shall, no later than the date as of which the value of an Award or of any Shares or other amounts received thereunder first becomes includable in the gross income of the grantee for income tax purposes, pay to the Company, or make arrangements satisfactory to the Committee regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by the Company with respect to such income. The Company and any Subsidiary shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company’s obligation to deliver stock certificates (or evidence of book entry) to any grantee is subject to and conditioned on any such tax withholding obligations being satisfied by the grantee.

The Company’s minimum required tax withholding obligation may be satisfied, in whole or in part, by the Company withholding from Shares to be issued pursuant to an Award a number of Shares having an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the minimum withholding amount due.

No Dissenters’ Rights

Under the Delaware General Corporation Law, the Stockholders are not entitled to dissenters’ rights with respect to the 2019 Plan, and the Company will not independently provide Stockholders with any such right.

27

Table of Contents

Vote Required

The affirmative vote of the holders of shares of common stock representing a majority of the shares of Common Stock cast at the meeting in person or by proxy is required for the approval of the proposed amendment to the Amended 2019 Plan to increase the maximum number of shares of the Company’s common stock available for issuance under the Amended 2019 Plan from 1,500,000 shares to 3,000,000 shares. Abstentions and broker non-votes will have no effect on the outcome of this proposal.

Recommendation of our Board

Our Board unanimously recommends that you vote “FOR” the approval of the proposed amendment to the 2019 Plan to increase the maximum number of shares of the Company’s common stock available for issuance under the 2019 Plan FROM 1,500,000shares TO 3,000,000 SHARES.

28

Table of Contents

Proposal No. 3:2: Non-Binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers.

Pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and Section 14A of the Exchange Act and related SEC rules, we are conducting a stockholder advisory vote on the compensation paid to our named executive officers. This proposal, commonly known as “say-on-pay,” gives our stockholders the opportunity to express their views on our named executive officers’ compensation. The vote is advisory and, therefore, it is not binding on ourthe Board, ourthe Compensation Committee, or the Company. Nevertheless, ourthe Compensation Committee will take into account the outcome of the vote when considering future executive compensation decisions. We currently intend to conduct this advisory vote annually, subject toin accordance with the outcome of the advisory vote on the frequency of future advisory votes on named executive officer compensation as discussedat the annual meeting of our stockholders held in Proposal No. 5.2022.

Our executive compensation program is designed to attract, motivate, and retain our named executive officers who are critical to our success. OurThe Board believes that our executive compensation program is well tailored to retain and motivate key executives while recognizing the need to align our executive compensation program with the interests of our stockholders and our “pay-for-performance” philosophy. OurThe Compensation Committee continually reviews the compensation programs for our named executive officers to ensure that they achieve the desired goals of aligning our executive compensation structure with our stockholders’ interests and current market practices.

We encourage our stockholders to readreview the “Summary Compensation Table”summary compensation table and other related compensation tables and narrative disclosures in the “Executive Compensation”Executive Compensation section of this Proxy Statement,proxy statement, which describediscusses the 2020 compensation of our named executive officers.officers during the years ended December 31, 2022 and 2021.

We are asking our stockholders to approve, on an advisory basis, the following non-binding, advisory resolution pursuant to this proposal:

RESOLVED, that the stockholders of Quantum Computing Inc. (the “Company”) approve, on an advisory basis, the compensation of ourthe Company’s named executive officers as disclosed in this Proxy Statementthe proxy statement for the 2023 annual meeting of stockholders pursuant to Item 402 of Regulation S-K, including the compensation tables and the narrative disclosures that accompany the compensation tables.

Vote Required

The affirmative vote ofVotes may be cast “FOR,” “AGAINST” or “ABSTAIN” with respect to this proposal. Assuming a quorum is present, the holders of shares of common stock representing a majority of the shares of Common Stock cast at the meeting in person or by proxy is required for the approval,proposal to approve, on a non-binding advisory basis, of the compensation of the Company’s named executive officers as disclosed in this Proxy Statement.proxy statement requires the approval of a majority of the votes cast on this proposal. Abstentions and broker non-votes are not included in calculating votes cast with respect to this proposal and will have no effect on the outcome of the vote on this proposal.

Recommendation of ourthe Board

OurTHE Board unanimously recommends that you vote “FOR” the approval on aoF THE non-binding advisory basis, ofRESOLUTION TO APPROVE the compensation of the Company’s named executive officers as disclosed in THIS proxy statement.

2926

Table of Contents

Proposal No. 4: Non-Binding Advisory on the Frequency of Future Advisory Votes to Approve the Compensation of the Company’s Named Executive Officers

In Proposal No. 3, we are providing our stockholders the opportunity to vote to approve, on an advisory, non-binding basis, the compensation of our named executive officers. In this Proposal No. 4, we are asking our stockholders to cast a non-binding advisory vote regarding the frequency of future executive compensation advisory votes. Stockholders may vote for a frequency of every one, two, or three years, or may abstain. This vote is required by Section 14A of the Exchange Act.

Our Board will take into consideration the outcome of this vote in making a determination about the frequency of future executive compensation advisory votes. However, because this vote is advisory and non-binding, our Board may decide that it is in the best interests of our stockholders and the Company to hold the advisory vote to approve executive compensation more or less frequently.

In the future, we will propose an advisory vote on the frequency of the executive compensation advisory vote at least once every six calendar years.

After careful consideration, our Board believes that the executive compensation advisory vote should be held annually, and therefore our Board unanimously recommends that you vote for a frequency of ONE YEAR for future executive compensation advisory votes. Our Board believes that an annual executive compensation advisory vote will facilitate more direct stockholder input about executive compensation. An annual executive compensation advisory vote is consistent with our policy of reviewing our compensation program annually, as well as seeking frequent input from our stockholders on corporate governance and executive compensation matters.

The approval of this Proposal No. 4 requires the affirmative vote of the holders of shares of common stock representing a majority of the shares of Common Stock cast at the meeting in person or by proxy. However, because stockholders have several voting choices with respect to this proposal, it is possible that no single choice will receive a majority vote. In light of the foregoing, our Board will consider the outcome of the vote when determining the frequency of future non-binding advisory votes on executive compensation. Moreover, because this vote is non-binding, our Board may determine the frequency of future advisory votes on executive compensation in its discretion.

Vote Required

The selection of the three options presented receiving the highest number of votes for such option will be the option recommended by stockholders, on a non-binding advisory basis, for the frequency of future advisory votes on the compensation of the Company’s named executive officers. Abstentions and broker non-votes will have no effect on the outcome of this proposal.

Recommendation of our Board

Our Board unanimously recommends that you vote FOR “ONE YEAR” as the preferred frequency of future advisory votes on the compensation of our named executive officers.

30

Table of Contents

Proposal No. 5:3: RatifICATION OF the Selection of bf borgers cpa pc as THE COMPANY’S Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 20212023

The Audit Committee of ourthe Board of Directors has selected the firm of BF Borgers CPA PC as our independent registered public accounting firm for the fiscal year ending December 31, 2021.2023. BF Borgers CPA PC has served as our independent registered public accounting firm since 2019.

A representative of BF Borgers CPA PC will not be present at the fiscal year ended December 31, 2018. Annual Meeting.

Although stockholder ratification of the selection of BF Borgers CPA PC is not required by Delaware law, or Delaware rules, ourthe Audit Committee believes that it is advisable and has decided to give our stockholders the opportunity to ratify this selection. If this proposal is not approved at the Annual Meeting, ourthe Audit Committee may reconsider this selection.selection and may retain that firm or another firm without resubmitting the matter to the Company’s stockholders. Even if the appointment is ratified, the Audit Committee may, in its discretion, direct the appointment of different independent public accountants at any time during the year if it determines that such change would be in the best interests the Company and its stockholders.

Vote Required

Votes may be cast FOR,” “AGAINST” or “ABSTAINwith respect to this proposal. The affirmative vote of the holders of shares of common stock representing a majority of the shares of Common Stock cast is required for the ratification ofproposal to ratify the selection of BF Borgers CPA PC as our independent registered public accounting firm for the current fiscal year.year requires the approval of a majority of the votes cast on this proposal. Abstentions will have no effect on the outcome of the vote on this proposal. There will be no broker non-votes with respect to this proposal.

Recommendation of ourthe Board

OURTHE BOARD unanimously RECOMMENDS THAT YOU VOTE “FOR” THE RATIFICATION OF THE SELECTION OF BF BORGERS CPA PC AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER31, 2021.2023.

3127

Table of Contents

OTHER BUSINESS

We have not received notice of and do not expect any other matters to be presented for vote at the Annual Meeting, other than the proposals described in this Proxy Statement. However, ifproxy statement. If, however, any other matters are properly presented to the Annual Meeting, it is the intention of the personsperson named in the accompanying proxy to vote, or otherwise act, in accordance with their judgment on such matters. If you grant a proxy, the person named as proxy holder, Robert Liscouski, or theirhis nominees or substitutes, will have the discretion to vote your shares on any additional matters properly presented for a vote at the Annual Meeting. If for any unforeseen reason, any of our nominees are not available as a candidate for director, the proxy holder will vote your proxy for such other candidate or candidates nominated by the Board.

28

Table of Contents

STOCKHOLDER PROPOSALS

In order to be included in the proxy materials for the Company’s 2024 annual meeting of stockholders, stockholder proposals submitted to us in compliance with SEC Rule 14a-8 (which concerns stockholder proposals that are requested to be included in a company’s proxy statement) must be received in written form at the Company’s executive offices on or before May 31, 2024. If we move the date of our Board.2024 annual meeting of stockholders more than 30 days from the date of the Annual Meeting, we will disclose an updated deadline by which such stockholder proposals must be submitted in a Quarterly Report on Form 10-Q that we file with the SEC. In order to curtail controversy as to compliance with this requirement, stockholders are urged to submit proposals to the Company’s Secretary by Certified Mail — Return Receipt Requested.

Pursuant to the proxy rules under the Exchange Act, Company stockholders are notified that the notice of any stockholder proposal to be submitted outside of the Rule 14a-8 process, for consideration at the 2024 annual meeting of stockholders, and any nominations for election the Board at such annual meeting, even if the nomination is not to be included in the proxy statement for such meeting, pursuant to our bylaws must be received by our Secretary between July 10, 2024 and August 9, 2024; provided, however, that if the date of the 2024 annual meeting is advanced more than 30 days prior to November 7, 2024 or is delayed more than 70 days after such date, then to be timely such notice must be received by the Company no earlier than the close of business 120 days prior to the date of such annual meeting and no later than the close of business 90 days prior to the date later of such annual meeting or the 10th day following the day on which public announcement of the date of the meeting is made.

Please see our bylaws for a description of the information that must be contained in a notice for a stockholder proposal or director nomination.

Finally, any person that intends to solicit proxies in support of director nominees other than the Company’s nominees at the Company’s 2024 annual meeting of stockholders pursuant to Rule 14a–19 under the Exchange Act must provide notice to the Company, which notice must be postmarked or transmitted electronically to the Company at its principal executive office no later than September 27, 2024, unless the date of the 2024 annual meeting changes by more than 30 calendar days from the first anniversary of the date of the Annual Meeting, in which case such notice must be provided by the later of 60 calendar days prior to the date of the 2024 annual meeting or the 10th calendar day following the day on which we first make a public announcement of the date of the 2024 annual meeting. Such notice must include the names of all nominees for whom such person intends to solicit proxies and a statement that such person intends to solicit the holders of shares representing at least 67% of the voting power of shares entitled to vote on the election of directors in support of director nominees other than the Company’s nominees.

29

Table of Contents

HOUSEHOLDING OF ANNUAL MEETING MATERIALS

The SEC has adopted rules that permit companies and intermediaries such as brokers to satisfy delivery requirements for the proxy statements and annual reports or Notices of Internet Availability of Proxy Materials, as applicable, with respect to two or more stockholders sharing the same address by delivering a single proxy statement and annual report or the Notice of Internet Availability of Proxy Materials, as applicable, addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially provides extra convenience for stockholders and cost savings for companies. We and some brokers household proxy materials, delivering a single proxy statement and annual report or the Notice of Internet Availability of Proxy Materials, as applicable, to multiple stockholders sharing an address unless contrary instructions have been received from one or more of the affected stockholders. Once you have received notice from your broker or us that they or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement and annual report, or the Notice of Internet Availability of Proxy Materials, as applicable, or if you are receiving multiples copies of the proxy statement and annual report or the Notice of Internet Availability of Proxy Materials, as applicable, and wish to receive only one, please notify your broker if your shares are held in a brokerage account or us if you hold registered shares. You can notify us by sending a written request addressed to Attn: Chief Executive Officer, Quantum Computing Inc., 215 Depot Court SE, Suite 215, Leesburg, VA 20175. We will deliver promptly, upon written request, a separate copy of the proxy statement and annual report or the Notice of Internet Availability of Proxy Materials, as applicable, to a registered stockholder at a shared address to which a single copy of the applicable document(s) was delivered.

In addition, we are subject to the information and reporting requirements of the Securities Exchange Act of 1934, as amended, and in accordance therewith, we file periodic reports, documents, and other information with the SEC relating to our business, financial statements and other matters. Such reports and other information may be inspected and are available for copying at the offices of the SEC, 100 F Street, N.E., Washington, D.C. 20549 or may be accessed at www.sec.gov. Information regarding the operation of the public reference rooms may be obtained by calling the SEC at 1-800-SEC-0330. You are encouragedWe encourage you to review our Annual Report on Form 10-K, together with any subsequent information we filed or will file with the SEC, and other publicly available information.

*************

32

Table of Contents

It is important that the proxies be returned promptly and that your shares be represented. Stockholders are urged to mark, date, execute and promptly return the accompanying proxy card.

September 28, 202127, 2023

 

By Order of the Board of Directors,

  

/s/ Robert Liscouski

  

Robert Liscouski

  

Chief Executive Officer and
Chairman of the Board of Directors

3330

Table of Contents

(The following is the text of the proposed First Amendment to the 2019 Equity and Incentive Plan. This text is followed by the current text of the 2019 Equity and Incentive Plan (without giving effect to the proposed amendment.)

FIRST AMENDMENT TO
QUANTUM COMPUTING INC.
2019 EQUITY AND INCENTIVE PLAN

WHEREAS, Quantum Computing Inc. (the “Company”) desires to amend the Quantum Computing Inc. 2019 Equity and Incentive Plan (the “Plan”) to increase the aggregate number of shares authorized for issuance under the Plan from 1,500,000 shares to 3,000,000 shares common stock, $0.0001 par value per share, of the Company (the “Common Stock”) (the “Plan Amendment”); and

WHEREAS, on July 22, 2021, subject to stockholder approval, the Board of Directors of the Company approved the Plan Amendment.

NOW, THEREFORE, in accordance with Section 11 of the Plan, the Plan is hereby amended as follows:

1.      Section 3(a) of the Plan is hereby amended by deleting paragraph 3(a) thereof in its entirety and substituting the following in lieu thereof:

“(a) Stock Issuable.    The maximum number of Shares reserved and available for issuance under the Plan shall be 3,000,000 Shares, subject to adjustment as provided in Section 3(b). For purposes of this limitation, the Shares underlying any Awards that are forfeited, canceled, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) shall be added back to the Shares available for issuance under the Plan. Subject to such overall limitations, Shares may be issued up to such maximum number pursuant to any type or types of Award, and no more than 250,000 Shares may be issued pursuant to Incentive Stock Options, as otherwise limited by Section 5(b) hereof, Code Section 422 and the regulations promulgated hereunder. The Shares available for issuance under the Plan may be authorized but unissued Shares or Shares reacquired by the Company. The value of any Shares granted to a non-employee director of the Company, when added to any annual cash payments or awards, shall not exceed an aggregate value of four hundred thousand dollars ($400,000) in any calendar year.

2.      The Plan Amendment shall be effective upon approval of the stockholders of the Company at the 2021 Annual Meeting of Stockholders. If the Plan Amendment is not so approved at such meeting, then the amendment to the Plan set forth herein shall be void ab initio.

3.      Except herein provided, the Plan is hereby ratified, confirmed and approved in all respects.

34

Table of Contents

Annex A

QUANTUM COMPUTING INC.
2019 EQUITY AND INCENTIVE PLAN

SECTION 1. GENERAL PURPOSE OF THE PLAN: DEFINITIONS

The name of the plan is the QUANTUM COMPUTING INC. 2019 EQUITY AND INCENTIVE PLAN (the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key persons of QUANTUM COMPUTING INC., a Delaware corporation (including any successor entity, the “Company”) and its Subsidiaries, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.

The following terms shall be defined as set forth below:

“Affiliate” of any Person means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with the first mentioned Person. A Person shall be deemed to control another Person if such first Person possesses directly or indirectly the power to direct, or cause the direction of, the management and policies of the second Person, whether through the ownership of voting securities, by contract or otherwise.

“Award” or “Awards,” except where referring to a particular category of grant under the Plan, shall include Incentive Stock Options, Non-Qualified Stock Options, Stock Appreciation Rights (“SAR”), Restricted Stock Awards (including preferred stock), Unrestricted Stock Awards, Restricted Stock Units or any combination of the foregoing.

“Award Agreement” means a written or electronic agreement setting forth the terms and provisions applicable to an Award granted under the Plan. Each Award Agreement may contain terms and conditions in addition to those set forth in the Plan; provided, however, in the event of any conflict in the terms of the Plan and the Award Agreement, the terms of the Plan shall govern.

“Board” means the Board of Directors of the Company.

“Cause” shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not contain a definition of “Cause,” it shall mean (i) the grantee’s dishonest statements or acts with respect to the Company or any Affiliate of the Company, or any current or prospective customers, suppliers vendors or other third parties with which such entity does business; (ii) the grantee’s commission of (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud; (iii) the grantee’s failure to perform his assigned duties and responsibilities to the reasonable satisfaction of the Company which failure continues, in the reasonable judgment of the Company, after written notice given to the grantee by the Company; (iv) the grantee’s gross negligence, willful misconduct or insubordination with respect to the Company or any Affiliate of the Company; or (v) the grantee’s material violation of any provision of any agreement(s) between the grantee and the Company relating to noncompetition, nonsolicitation, nondisclosure and/or assignment of inventions.

“Chief Executive Officer” means the Chief Executive Officer of the Company or, if there is no Chief Executive Officer, then the President of the Company.

“Code” means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.

“Committee” means the Committee of the Board referred to in Section 2.

“Consultant” means any entity or natural person that provides bona fide services to the Company (including a Subsidiary), and such services are not in connection with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company’s securities.

“Disability” means such condition which renders a Person (A) unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expect to last for a continuous period of not less than 12 months, (B) by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous

Annex A-1

Table of Contents

period of not less than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering employees of the Company, (C) determined to be totally disabled by the Social Security Administration, or (D) determined to be disabled under a disability insurance program which provides for a definition of disability that meets the requirements of this section.

“Effective Date” means the date on which the Plan is adopted as set forth in this Plan.

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

“Fair Market Value” of the Stock on any given date means the fair market value of the Stock determined in good faith by the Committee based on the reasonable application of a reasonable valuation method that is consistent with Section 409A of the Code. If the Stock is admitted to trade on a national securities exchange, the determination shall be made by reference to the closing price reported on such exchange. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date for which there is a closing price. If the date for which Fair Market Value is determined is the first day when trading prices for the Stock are reported on a national securities exchange, the Fair Market Value shall be the “Price to the Public” (or equivalent).

“Good Reason” shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not contain a definition of “Good Reason,” it shall mean (i) a material diminution in the grantee’s base salary except for across-the-board salary reductions similarly affecting all or substantially all similarly situated employees of the Company or (ii) a change of more than 100 miles in the geographic location at which the grantee provides services to the Company, so long as the grantee provides notice of the condition giving rise to Good Reason no more than 90 days from the date on which such event occurred which gave rise to Good Reason for Termination of the Service Relationship, and the Company fails to cure such event within 30 days after such notice.

“Grant Date” means the date that the Committee designates in its approval of an Award in accordance with applicable law as the date on which the Award is granted, which date may not precede the date of such Committee approval.

“Holder” means, with respect to an Award or any Shares, the Person holding such Award or Shares, including the initial recipient of the Award or any Permitted Transferee.

“Incentive Stock Option” means any Stock Option designated and qualified as an “incentive stock option” as defined in Section 422 of the Code.

“Non-Qualified Stock Option” means any Stock Option that is not an Incentive Stock Option.

“Option” or “Stock Option” means any option to purchase shares of Stock granted pursuant to Section 5.

“Permitted Transferees” shall mean any of the following to whom a Holder may transfer Shares hereunder (as set forth in Section 9(a)(ii)(A)): the Holder’s child, stepchild, grandchild, parent, step-parent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the Holder’s household (other than a tenant or employee), a trust in which these persons have more than fifty percent of the beneficial interest, a foundation in which these persons control the management of assets, and any other entity in which these persons own more than fifty percent of the voting interests; provided, however, that any such trust does not require or permit distribution of any Shares during the term of the Award Agreement unless subject to its terms. Upon the death of the Holder, the term Permitted Transferees shall also include such deceased Holder’s estate, executors, administrators, personal representatives, heirs, legatees and distributees, as the case may be.

“Person” shall mean any individual, corporation, partnership (limited or general), limited liability company, limited liability partnership, association, trust, joint venture, unincorporated organization or any similar entity.

“Restricted Stock Award” means Awards granted pursuant to Section 7 and “Restricted Stock” means Shares issued pursuant to such Awards.

“Restricted Stock Unit” means an Award of phantom stock units to a grantee, which may be settled in cash or Shares as determined by the Committee, pursuant to Section 8.

Annex A-2

Table of Contents

“Sale Event” means the consummation of i) a change in the ownership of the Company, ii) a change in effective control of the Company, or iii) a change in the ownership of a substantial portion of the assets of the Company. The occurrence of a Sale Event shall be acknowledged by the plan administrator or board of directors, by strictly applying these provisions without any discretion to deviate from the objective application of the definitions provided herein. ; provided, however, that any capital raising event, or a merger effected solely to change the Company’s domicile shall not constitute a “Sale Event.”

Except as otherwise provided herein, a change in the ownership of the Company occurs on the date that any one person, or more than one person acting as a group acquires ownership of stock of the Company that, together with stock held by such person or group, constitutes more than 50 percent of the total fair market value or total voting power of the stock of the Company. However, if any one person, or more than one person acting as a group, is considered to own more than 50 percent of the total fair market value or total voting power of the stock of the Company the acquisition of additional stock by the same person or persons is not considered to cause a change in the ownership of the Company (or to cause a change in the effective control of the Company). An increase in the percentage of stock owned by any one person, or persons acting as a group, as a result of a transaction in which the corporation acquires its stock in exchange for property will be treated as an acquisition of stock for purposes of this section. This section applies only when there is a transfer of stock of the Company (or issuance of stock) which remains outstanding after the transaction.

A change in the effective control of the Company occurs only on either of the following dates: (1) The date any one person, or more than one person acting as a group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company possessing 30 percent or more of the total voting power of the stock of the Company; (2) The date a majority of members of the Company’s board of directors is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Company’s board of directors before the date of the appointment or election.

A change in the ownership of a substantial portion of the Company’s assets occurs on the date that any one person, or more than one person acting as a group acquires (or has acquired during the 12- month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 40 percent of the total gross fair market value of all of the assets of the Company immediately before such acquisition or acquisitions. For this purpose, gross fair market value means the value of the assets of the corporation, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

“Section 409A” means Section 409A of the Code and the regulations and other guidance promulgated thereunder.

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder.

“Service Relationship” means any relationship as a full-time employee, part-time employee, director or other key person (including Consultants) of the Company or any Subsidiary or any successor entity (e.g., a Service Relationship shall be deemed to continue without interruption in the event an individual’s status changes from full-time employee to part-time employee or Consultant).

“Shares” means shares of Stock.

“Stock” means the Common Stock, par value $0.0001 per share, of the Company.

“Stock Appreciation Right” means any right to receive from the Company upon exercise by an optionee or settlement, in cash, Shares, or a combination thereof, the excess of (i) the Fair Market Value of one Share on the date of exercise or settlement over (ii) the exercise price of the right on the date of grant, or if granted in connection with an Option, on the date of grant of the Option.

“Subsidiary” means any corporation or other entity (other than the Company) in which the Company has more than a 50 percent interest, either directly or indirectly.

“Ten Percent Owner” means an employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10 percent of the combined voting power of all classes of stock of the Company or any parent of the Company or any Subsidiary.

Annex A-3

Table of Contents

“Termination Event” means the termination of the Award recipient’s Service Relationship with the Company and its Subsidiaries for any reason whatsoever, regardless of the circumstances thereof, and including, without limitation, upon death, disability, retirement, discharge or resignation for any reason, whether voluntarily or involuntarily. The following shall not constitute a Termination Event: (i) a transfer to the service of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another Subsidiary or (ii) an approved leave of absence for military service or sickness, or for any other purpose approved by the Committee, if the individual’s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides in writing.

“Unrestricted Stock Award” means any Award granted pursuant to Section 7 and “Unrestricted Stock” means Shares issued pursuant to such Awards.

SECTION 2. ADMINISTRATION OF PLAN; COMMITTEE AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS

(a) Administration of Plan. The Plan shall be administered by the Board, or at the discretion of the Board, by a committee of the Board, comprised of not less than two directors. All references herein to the “Committee” shall be deemed to refer to the group then responsible for administration of the Plan at the relevant time (i.e., either the Board of Directors or a committee or committees of the Board, as applicable).

(b) Powers of Committee. The Committee shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority:

(i) to select the individuals to whom Awards may from time to time be granted;

(ii) to determine the time or times of grant, and the amount, if any, of Incentive Stock Options, Non-Qualified Stock Options, SARs, Restricted Stock Awards, Unrestricted Stock Awards, Restricted Stock Units, or any combination of the foregoing, granted to any one or more grantees;

(iii) to determine the number and types of Shares to be covered by any Award and, subject to the provisions of the Plan, the price, exercise price, conversion ratio or other price relating thereto;

(iv) to determine and, subject to Section 12, to modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the form of Award Agreements;

(v) to accelerate at any time the exercisability or vesting of all or any portion of any Award;

(vi) to impose any limitations on Awards, including limitations on transfers, repurchase provisions and the like, and to exercise repurchase rights or obligations;

(vii) subject to Section 5(a)(ii) and any restrictions imposed by Section 409A, to extend at any time the period in which Stock Options may be exercised; and

(viii) at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including Award Agreements); to make all determinations it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and to otherwise supervise the administration of the Plan.

All decisions and interpretations of the Committee shall be binding on all persons, including the Company and all Holders.

(c) Award Agreement. Awards under the Plan shall be evidenced by Award Agreements that set forth the terms, conditions and limitations for each Award.

(d) Indemnification. Neither the Board nor the Committee, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Committee (and any delegate thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including,

Annex A-4

Table of Contents

without limitation, reasonable attorneys’ fees) arising or resulting therefrom to the fullest extent permitted by law and/or under the Company’s governing documents, including its certificate of incorporation or bylaws, or any directors’ and officers’ liability insurance coverage which may be in effect from time to time and/or any indemnification agreement between such individual and the Company.

(e) Foreign Award Recipients. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company and any Subsidiary operate or have employees or other individuals eligible for Awards, the Committee, in its sole discretion, shall have the power and authority to: (i) determine which Subsidiaries, if any, shall be covered by the Plan; (ii) determine which individuals, if any, outside the United States are eligible to participate in the Plan; (iii) modify the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws; (iv) establish subplans and modify exercise procedures and other terms and procedures, to the extent the Committee determines such actions to be necessary or advisable (and such subplans and/or modifications shall be attached to the Plan as appendices); provided, however, that no such subplans and/or modifications shall increase the share limitation contained in Section 3(a) hereof; and (v) take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals.

SECTION 3. STOCK ISSUABLE UNDER THE PLAN; MERGERS AND OTHER TRANSACTIONS; SUBSTITUTION

(a) Stock Issuable. The maximum number of Shares reserved and available for issuance under the Plan shall be 1,500,000 Shares, subject to adjustment as provided in Section 3(b). For purposes of this limitation, the Shares underlying any Awards that are forfeited, canceled, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) shall be added back to the Shares available for issuance under the Plan . Subject to such overall limitations, Shares may be issued up to such maximum number pursuant to any type or types of Award, and no more than 250,000 Shares may be issued pursuant to Incentive Stock Options. The Shares available for issuance under the Plan may be authorized but unissued Shares or Shares reacquired by the Company. The value of any Shares granted to a non-employee director of the Company, when added to any annual cash payments or awards, shall not exceed an aggregate value of four hundred thousand dollars ($400,000) in any calendar year.

(b) Changes in Stock. Subject to Section 3(c) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in the Company’s capital stock, the outstanding Shares are increased or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional Shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares or other securities, in each case, without the receipt of consideration by the Company, or, if, as a result of any merger or consolidation, or sale of all or substantially all of the assets of the Company, the outstanding Shares are converted into or exchanged for other securities of the Company or any successor entity (or a parent or subsidiary thereof), the Committee shall make an appropriate and proportionate adjustment in (i) the maximum number of Shares reserved for issuance under the Plan, (ii) the number and kind of Shares or other securities subject to any then outstanding Awards under the Plan, (iii) the repurchase price, if any, per Share subject to each outstanding Award, and (iv) the exercise price for each Share subject to any then outstanding Stock Options under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of Stock Options) as to which such Stock Options remain exercisable. The Committee shall in any event make such adjustments as may be required by the laws of Delaware and the rules and regulations promulgated thereunder. The adjustment by the Committee shall be final, binding and conclusive. No fractional Shares shall be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a cash payment in lieu of fractional shares.

(c) Sale Events.

(i) Options.

(A) In the case of and subject to the consummation of a Sale Event, the Plan and all outstanding Options and SARs issued hereunder shall become one hundred percent (100%) vested upon the effective time of any such Sale Event. New stock options or other awards of the successor entity or parent thereof shall be substituted

Annex A-5

Table of Contents

therefor, with an equitable or proportionate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as such parties shall agree (after taking into account any acceleration hereunder and/or pursuant to the terms of any Award Agreement).

(B) In the event of the termination of the Plan and all outstanding Options and SARs issued hereunder pursuant to Section 3(c), each Holder of Options shall be permitted, within a period of time prior to the consummation of the Sale Event as specified by the Committee, to exercise all such Options or SARs which are then exercisable or will become exercisable as of the effective time of the Sale Event; provided, however, that the exercise of Options not exercisable prior to the Sale Event shall be subject to the consummation of the Sale Event.

(C) Notwithstanding anything to the contrary in Section 3(c)(i)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation, to make or provide for a cash payment to the Holders of Options, without any consent of the Holders, in exchange for the cancellation thereof, in an amount equal to the difference between (A) the value as determined by the Committee of the consideration payable per share of Stock pursuant to the Sale Event (the “Sale Price”) times the number of Shares subject to outstanding Options being cancelled (to the extent then vested and exercisable, including by reason of acceleration in connection with such Sale Event, at prices not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding vested and exercisable Options.

(ii) Restricted Stock and Restricted Stock Unit Awards.

(A) In the case of and subject to the consummation of a Sale Event, all unvested Restricted Stock and unvested Restricted Stock Unit Awards issued hereunder shall become one hundred percent (100%) vested, with an equitable or proportionate adjustment as to the number and kind of shares subject to such awards as such parties shall agree (after taking into account any acceleration hereunder and/or pursuant to the terms of any Award Agreement).

(B) Such Restricted Stock shall be repurchased from the Holder thereof at the then Fair Market Value of such shares, (subject to adjustment as provided in Section 3(b)) for such Shares.

(C) Notwithstanding anything to the contrary in Section 3(c)(ii)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation, to make or provide for a cash payment to the Holders of Restricted Stock or Restricted Stock Unit Awards, without consent of the Holders, in exchange for the cancellation thereof, in an amount equal to the Sale Price times the number of Shares subject to such Awards, to be paid at the time of such Sale Event or upon the later vesting of such Awards.

SECTION 4. ELIGIBILITY

Grantees under the Plan will be such full or part-time officers and other employees, directors, Consultants and key persons of the Company and any Subsidiary who are selected from time to time by the Committee in its sole discretion; provided, however, that Awards shall be granted only to those individuals described in Rule 701(c) of the Securities Act.

SECTION 5. STOCK OPTIONS

Upon the grant of a Stock Option, the Company and the grantee shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards and grantees.

Stock Options granted under the Plan may be either Incentive Stock Options or Non-Qualified Stock Options. Incentive Stock Options may be granted only to employees of the Company or any Subsidiary that is a “subsidiary corporation” within the meaning of Section 424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock Option.

(a) Terms of Stock Options. The Committee in its discretion may grant Stock Options to those individuals who meet the eligibility requirements of Section 4. Stock Options shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem desirable.

(i) Exercise Price. The exercise price per share for the Shares covered by a Stock Option shall be determined by the Committee at the time of grant but shall not be less than 100 percent of the Fair Market Value on the Grant

Annex A-6

Table of Contents

Date. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the exercise price per share for the Shares covered by such Incentive Stock Option shall not be less than 110 percent of the Fair Market Value on the Grant Date.

(ii) Option Term. The term of each Stock Option shall be fixed by the Committee, but no Stock Option shall be exercisable more than ten years from the Grant Date. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option shall be no more than five years from the Grant Date.

(iii) Exercisability; Rights of a Stockholder. Stock Options shall become exercisable and/or vested at such time or times, whether or not in installments, as shall be determined by the Committee at or after the Grant Date. The Award Agreement may permit a grantee to exercise all or a portion of a Stock Option immediately at grant; provided that the Shares issued upon such exercise shall be subject to restrictions and a vesting schedule identical to the vesting schedule of the related Stock Option, such Shares shall be deemed to be Restricted Stock for purposes of the Plan, and the optionee may be required to enter into an additional or new Award Agreement as a condition to exercise of such Stock Option. An optionee shall have the rights of a stockholder only as to Shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options. An optionee shall not be deemed to have acquired any Shares unless and until a Stock Option shall have been exercised pursuant to the terms of the Award Agreement and this Plan and the optionee’s name has been entered on the books of the Company as a stockholder.

(iv) Method of Exercise. Stock Options may be exercised by an optionee in whole or in part, by the optionee giving written or electronic notice of exercise to the Company, specifying the number of Shares to be purchased. Payment of the purchase price may be made by one or more of the following methods (or any combination thereof) to the extent provided in the Award Agreement:

(A) In cash, by certified or bank check, by wire transfer of immediately available funds, or other instrument acceptable to the Committee;

(B) If permitted by the Committee, by the optionee delivering to the Company a promissory note, if the Board has expressly authorized the loan of funds to the optionee for the purpose of enabling or assisting the optionee to effect the exercise of his or her Stock Option; provided, that at least so much of the exercise price as represents the par value of the Stock shall be paid in cash if required by state law;

(C) If permitted by the Committee, through the delivery (or attestation to the ownership) of Shares that have been purchased by the optionee on the open market or that are beneficially owned by the optionee and are not then subject to restrictions under any Company plan. To the extent required to avoid variable accounting treatment under applicable accounting rules, such surrendered Shares if originally purchased from the Company shall have been owned by the optionee for at least six months. Such surrendered Shares shall be valued at Fair Market Value on the exercise date;

(D) If permitted by the Committee and by the optionee delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price; provided that in the event the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Committee shall prescribe as a condition of such payment procedure; or

(E) If permitted by the Committee, and only with respect to Stock Options that are not Incentive Stock Options, by a “net exercise” arrangement pursuant to which the Company will reduce the number of Shares issuable upon exercise by the largest whole number of Shares with a Fair Market Value that does not exceed the aggregate exercise price.

Payment instruments will be received subject to collection. No certificates for Shares so purchased will be issued to the optionee or, with respect to uncertificated Stock, no transfer to the optionee on the records of the Company will take place, until the Company has completed all steps it has deemed necessary to satisfy legal requirements relating to the issuance and sale of the Shares, which steps may include, without limitation, (i) receipt of a representation from the optionee at the time of exercise of the Option that the optionee is purchasing the Shares for the optionee’s own account and not with a view to any sale or distribution of the Shares or other representations relating to compliance with applicable law governing the issuance of securities, (ii) the legending of the certificate (or notation on any book entry) representing the Shares to evidence the foregoing restrictions, and (iii) obtaining from optionee payment or provision

Annex A-7

Table of Contents

for all withholding taxes due as a result of the exercise of the Option. The delivery of certificates representing the shares of Stock (or the transfer to the optionee on the records of the Company with respect to uncertificated Stock) to be purchased pursuant to the exercise of a Stock Option will be contingent upon (A) receipt from the optionee (or a purchaser acting in his or her stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such Shares and the fulfillment of any other requirements contained in the Award Agreement or applicable provisions of laws and (B) if required by the Company, the optionee shall have entered into any stockholders agreements or other agreements with the Company and/or certain other of the Company’s stockholders relating to the Stock. In the event an optionee chooses to pay the purchase price by previously-owned Shares through the attestation method, the number of Shares transferred to the optionee upon the exercise of the Stock Option shall be net of the number of Shares attested to by the Optionee.

(b) Annual Limit on Incentive Stock Options. To the extent required for “incentive stock option” treatment under Section 422 of the Code, the aggregate Fair Market Value (determined as of the Grant Date) of the Shares with respect to which Incentive Stock Options granted under the Plan and any other plan of the Company or its parent and any Subsidiary that become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000 or such other limit as may be in effect from time to time under Section 422 of the Code. To the extent that any Stock Option exceeds this limit, it shall constitute a Non-Qualified Stock Option.

(c) Termination. Any portion of a Stock Option that is not vested and exercisable on the date of termination of an optionee’s Service Relationship shall immediately expire and be null and void. Once any portion of the Stock Option becomes vested and exercisable, the optionee’s right to exercise such portion of the Stock Option (or the optionee’s representatives and legatees as applicable) in the event of a termination of the optionee’s Service Relationship shall continue until the earliest of: (i) the date which is: (A) 12 months following the date on which the optionee’s Service Relationship terminates due to death or Disability (or such longer period of time as determined by the Committee and set forth in the applicable Award Agreement), or (B) three months following the date on which the optionee’s Service Relationship terminates if the termination is due to any reason other than death or Disability (or such longer period of time as determined by the Committee and set forth in the applicable Award Agreement), or (ii) the Expiration Date set forth in the Award Agreement; provided that notwithstanding the foregoing, an Award Agreement may provide that if the optionee’s Service Relationship is terminated for Cause, the Stock Option shall terminate immediately and be null and void upon the date of the optionee’s termination and shall not thereafter be exercisable.

SECTION 6. STOCK APPRECIATION RIGHTS

The Committee is authorized to grant SARs to optionees with the following terms and conditions and with such additional terms and conditions, in either case not inconsistent with the provisions of the Plan, as the Committee shall determine —

(a) SARs may be granted under the Plan to optionees either alone or in addition to other Awards granted under the Plan and may, but need not, relate to specific Option granted under Section 5.

(b) The exercise price per Share under a SAR shall be determined by the Committee, provided, however, that except in the case of a substitute Award, such exercise price shall not be less than the fair market value of a Share on the date of grant of such SAR.

(c) The term of each SAR shall be fixed by the Committee but shall not exceed 10 years from the date of grant of such SAR.

(d) The Committee shall determine the time or times at which a SAR may be exercised or settled in whole or in part. Unless otherwise determined by the Committee or unless otherwise set forth in an Award Agreement, the provisions set forth in Section 5 above with respect to exercise of an Award following termination of service shall apply to any SAR. The Committee may specify in an Award Agreement that an “in-the-money” SAR shall be automatically exercised on its expiration date.

Annex A-8

Table of Contents

SECTION 7. RESTRICTED STOCK AWARDS

(a) Nature of Restricted Stock Awards. The Committee may, in its sole discretion, grant (or sell at par value or such other purchase price determined by the Committee) to an eligible individual under Section 4 hereof a Restricted Stock Award under the Plan. The Committee shall determine the restrictions and conditions applicable to each Restricted Stock Award at the time of grant. Conditions may be based on the type of stock upon which restrictions are placed, continuing employment (or other Service Relationship), achievement of pre-established performance goals and objectives and/or such other criteria as the Committee may determine. Upon the grant of a Restricted Stock Award, the Company and the grantee shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards and grantees.

(b) Rights as a Stockholder. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee of Restricted Stock shall be considered the record owner of and shall be entitled to vote the Restricted Stock if, and to the extent, such Shares are entitled to voting rights, subject to such conditions contained in the Award Agreement. The grantee shall be entitled to receive all dividends and any other distributions declared on the Shares; provided, however, that the Company is under no duty to declare any such dividends or to make any such distribution. Unless the Committee shall otherwise determine, certificates evidencing the Restricted Stock shall remain in the possession of the Company until such Restricted Stock is vested as provided in subsection (d) below of this Section, and the grantee shall be required, as a condition of the grant, to deliver to the Company a stock power endorsed in blank and such other instruments of transfer as the Committee may prescribe.

(c) Restrictions. Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or in the Award Agreement. Except as may otherwise be provided by the Committee either in the Award Agreement or, subject to Section 12 below, in writing after the Award Agreement is issued, if a grantee’s Service Relationship with the Company and any Subsidiary terminates, the Company or its assigns shall have the right, as may be specified in the relevant instrument, to repurchase some or all of the Shares subject to the Award at such purchase price as is set forth in the Award Agreement.

(d) Vesting of Restricted Stock. The Committee at the time of grant shall specify in the Award Agreement the date or dates and/or the attainment of pre-established performance goals, objectives and other conditions on which the substantial risk of forfeiture imposed shall lapse and the Restricted Stock shall become vested, subject to such further rights of the Company or its assigns as may be specified in the Award Agreement.

SECTION 8. UNRESTRICTED STOCK AWARDS

The Committee may, in its sole discretion, grant (or sell at par value or such other purchase price determined by the Committee) to an eligible person under Section 4 hereof an Unrestricted Stock Award under the Plan. Unrestricted Stock Awards may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee.

SECTION 9. RESTRICTED STOCK UNITS

(a) Nature of Restricted Stock Units. The Committee may, in its sole discretion, grant to an eligible person under Section 4 hereof Restricted Stock Units under the Plan. The Committee shall determine the restrictions and conditions applicable to each Restricted Stock Unit at the time of grant. Vesting conditions may be based on continuing employment (or other Service Relationship), achievement of pre-established performance goals and objectives which may be based on targets for revenue, revenue growth, EBITDA, net income, earnings per share and/or other such criteria as the Committee may determine. Upon the grant of Restricted Stock Units, the grantee and the Company shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined by the Committee and may differ among individual Awards and grantees. On or promptly following the vesting date or dates applicable to any Restricted Stock Unit, but in no event later than March 15 of the year following the year in which such vesting occurs, such Restricted Stock Unit(s) shall be settled in the form of cash or shares of Stock, as specified in the Award Agreement. Restricted Stock Units may not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of.

Annex A-9

Table of Contents

(b) Rights as a Stockholder. A grantee shall have the rights of a stockholder only as to Shares, if any, acquired upon settlement of Restricted Stock Units. A grantee shall not be deemed to have acquired any such Shares unless and until the Restricted Stock Units shall have been settled in Shares pursuant to the terms of the Plan and the Award Agreement, the Company shall have issued and delivered a certificate representing the Shares to the grantee (or transferred on the records of the Company with respect to uncertificated stock), and the grantee’s name has been entered in the books of the Company as a stockholder.

(c) Termination. Except as may otherwise be provided by the Committee either in the Award Agreement or in writing after the Award Agreement is issued, a grantee’s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee’s cessation of Service Relationship with the Company and any Subsidiary for any reason.

SECTION 10. TRANSFER RESTRICTIONS; COMPANY RIGHT OF FIRST REFUSAL; COMPANY REPURCHASE RIGHTS

(a) Restrictions on Transfer.

(i) Non-Transferability of Stock Options. Restricted Stock awards granted under Section 7, Stock Options, SARs and, prior to exercise, the Shares issuable upon exercise of such Stock Option, shall not be transferable by the optionee otherwise than by will, or by the laws of descent and distribution, and all Stock Options shall be exercisable, during the optionee’s lifetime, only by the optionee, or by the optionee’s legal representative or guardian in the event of the optionee’s incapacity. Notwithstanding the foregoing, the Committee, in its sole discretion, may provide in the Award Agreement regarding a given Stock Option or Restricted Stock award that the optionee may transfer by gift, without consideration for the transfer, his or her Non-Qualified Stock Options to his or her family members (as defined in Rule 701 of the Securities Act), to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners (to the extent such trusts or partnerships are considered “family members” for purposes of Rule 701 of the Securities Act), provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award Agreement, including the execution of a stock power upon the issuance of Shares. Stock Options, SARs and the Shares issuable upon exercise of such Stock Options, shall be restricted as to any pledge, hypothecation, or other transfer, including any short position, any “put equivalent position” (as defined in the Exchange Act) or any “call equivalent position” (as defined in the Exchange Act) prior to exercise.

(ii) Shares. No Shares shall be sold, assigned, transferred, pledged, hypothecated, given away or in any other manner disposed of or encumbered, whether voluntarily or by operation of law, unless (i) the transfer is in compliance with the terms of the applicable Award Agreement, all applicable securities laws (including, without limitation, the Securities Act), and with the terms and conditions of this Section 9, (ii) the transfer does not cause the Company to become subject to the reporting requirements of the Exchange Act, and the transferee consents in writing to be bound by the provisions of the Plan and the Award Agreement, including this Section 10. In connection with any proposed transfer, the Committee may require the transferor to provide at the transferor’s own expense an opinion of counsel to the transferor, satisfactory to the Committee, that such transfer is in compliance with all foreign, federal and state securities laws (including, without limitation, the Securities Act). Any attempted transfer of Shares not in accordance with the terms and conditions of this Section 9 shall be null and void, and the Company shall not reflect on its records any change in record ownership of any Shares as a result of any such transfer, shall otherwise refuse to recognize any such transfer and shall not in any way give effect to any such transfer of Shares. The Company shall be entitled to seek protective orders, injunctive relief and other remedies available at law or in equity including, without limitation, seeking specific performance or the rescission of any transfer not made in strict compliance with the provisions of this Section 10. Subject to the foregoing general provisions, and unless otherwise provided in the applicable Award Agreement, Shares may be transferred pursuant to the following specific terms and conditions (provided that with respect to any transfer of Restricted Stock, all vesting and forfeiture provisions shall continue to apply with respect to the original recipient):

(A) Transfers to Permitted Transferees. The Holder may transfer any or all of the Shares to one or more Permitted Transferees; provided, however, that following such transfer, such Shares shall continue to be subject to the terms of this Plan (including this Section 9) and such Permitted Transferee(s) shall, as a condition to any such transfer, deliver a written acknowledgment to that effect to the Company and shall deliver a stock power to the

Annex A-10

Table of Contents

Company with respect to the Shares. Notwithstanding the foregoing, the Holder may not transfer any of the Shares to a Person whom the Company reasonably determines is a direct competitor or a potential competitor of the Company or any of its Subsidiaries.

(B) Transfers Upon Death. Upon the death of the Holder, any Shares then held by the Holder at the time of such death and any Shares acquired after the Holder’s death by the Holder’s legal representative shall be subject to the provisions of this Plan, and the Holder’s estate, executors, administrators, personal representatives, heirs, legatees and distributees shall be obligated to convey such Shares to the Company or its assigns under the terms contemplated by the Plan and the Award Agreement.

(b) Right of First Refusal. In the event that a Holder desires at any time to sell or otherwise transfer all or any part of his or her Shares (other than shares of Restricted Stock which by their terms are not transferrable), the Holder first shall give written notice to the Company of the Holder’s intention to make such transfer. Such notice shall state the number of Shares that the Holder proposes to sell (the “Offered Shares”), the price and the terms at which the proposed sale is to be made and the name and address of the proposed transferee. At any time within 30 days after the receipt of such notice by the Company, the Company or its assigns may elect to purchase all or any portion of the Offered Shares at the price and on the terms offered by the proposed transferee and specified in the notice. The Company or its assigns shall exercise this right by mailing or delivering written notice to the Holder within the foregoing 30-day period. If the Company or its assigns elect to exercise its purchase rights under this Section 9(b), the closing for such purchase shall, in any event, take place within 45 days after the receipt by the Company of the initial notice from the Holder. In the event that the Company or its assigns do not elect to exercise such purchase right, or in the event that the Company or its assigns do not pay the full purchase price within such 45-day period, the Holder shall be required to pay a transaction processing fee of $10,000 to the Company (unless waived by the Committee) and then may, within 60 days thereafter, sell the Offered Shares to the proposed transferee and at the same price and on the same terms as specified in the Holder’s notice. Any Shares not sold to the proposed transferee shall remain subject to the Plan. If the Holder is a party to any stockholders agreements or other agreements with the Company and/or certain other of the Company’s stockholders relating to the Shares, (i) the transferring Holder shall comply with the requirements of such stockholders agreements or other agreements relating to any proposed transfer of the Offered Shares, and (ii) any proposed transferee that purchases Offered Shares shall enter into such stockholders agreements or other agreements with the Company and/or certain of the Company’s stockholders relating to the Offered Shares on the same terms and in the same capacity as the transferring Holder.

(c) Company’s Right of Repurchase.

(i) Right of Repurchase for Unvested Shares Issued Upon the Exercise of an Option. Upon a Termination Event, the Company or its assigns shall have the right and option to repurchase from a Holder of Shares acquired upon exercise of a Stock Option which is still subject to a risk of forfeiture as of the Termination Event. Such repurchase rights may be exercised by the Company within the later of (A) six months following the date of such Termination Event or (B) seven months after the acquisition of Shares upon exercise of a Stock Option. The repurchase price shall be equal to the lower of the original per share price paid by the Holder, subject to adjustment as provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its repurchase rights.

(ii) Right of Repurchase With Respect to Restricted Stock. Upon a Termination Event, the Company or its assigns shall have the right and option to repurchase from a Holder of Shares received pursuant to a Restricted Stock Award any Shares that are still subject to a risk of forfeiture as of the Termination Event. Such repurchase right may be exercised by the Company within six months following the date of such Termination Event. The repurchase price shall be the lower of the original per share purchase price paid by the Holder, subject to adjustment as provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its repurchase rights.

(iii) Procedure. Any repurchase right of the Company shall be exercised by the Company or its assigns by giving the Holder written notice on or before the last day of the repurchase period of its intention to exercise such repurchase right. Upon such notification, the Holder shall promptly surrender to the Company, free and clear of any liens or encumbrances, any certificates representing the Shares being purchased, together with a duly executed stock power for the transfer of such Shares to the Company or the Company’s assignee or assignees. Upon the Company’s or

Annex A-11

Table of Contents

its assignee’s receipt of the certificates from the Holder, the Company or its assignee or assignees shall deliver to him, her or them a check for the applicable repurchase price; provided, however, that the Company may pay the repurchase price by offsetting and canceling any indebtedness then owed by the Holder to the Company.

(d) Escrow Arrangement.

(i) Escrow. In order to carry out the provisions of this Section 9 of this Plan more effectively, the Company shall hold any Shares issued pursuant to Awards granted under the Plan in escrow together with separate stock powers executed by the Holder in blank for transfer. The Company shall not dispose of the Shares except as otherwise provided in this Plan. In the event of any repurchase by the Company (or any of its assigns), the Company is hereby authorized by the Holder, as the Holder’s attorney-in-fact, to date and complete the stock powers necessary for the transfer of the Shares being purchased and to transfer such Shares in accordance with the terms hereof. At such time as any Shares are no longer subject to the Company’s repurchase and first refusal rights, the Company shall, at the written request of the Holder, deliver to the Holder a certificate representing such Shares with the balance of the Shares to be held in escrow pursuant to this Section.

(ii) Remedy. Without limitation of any other provision of this Plan or other rights, in the event that a Holder or any other Person is required to sell a Holder’s Shares pursuant to the provisions of Sections 9(b) or (c) hereof and in the further event that he or she refuses or for any reason fails to deliver to the Company or its designated purchaser of such Shares the certificate or certificates evidencing such Shares together with a related stock power, the Company or such designated purchaser may deposit the applicable purchase price for such Shares with a bank designated by the Company, or with the Company’s independent public accounting firm, as agent or trustee, or in escrow, for such Holder or other Person, to be held by such bank or accounting firm for the benefit of and for delivery to him, her, them or it, and/or, in its discretion, pay such purchase price by offsetting any indebtedness then owed by such Holder as provided above. Upon any such deposit and/or offset by the Company or its designated purchaser of such amount and upon notice to the Person who was required to sell the Shares to be sold pursuant to the provisions of Sections 9(b) or (c), such Shares shall at such time be deemed to have been sold, assigned, transferred and conveyed to such purchaser, such Holder shall have no further rights thereto (other than the right to withdraw the payment thereof held in escrow, if applicable), and the Company shall record such transfer in its stock transfer book or in any appropriate manner.

(e) Lockup Provision. If requested by the Company, a Holder shall not sell or otherwise transfer or dispose of any Shares (including, without limitation, pursuant to Rule 144 under the Securities Act) held by him or her for such period following the effective date of a public offering by the Company of Shares as the Company shall specify reasonably and in good faith. If requested by the underwriter engaged by the Company, each Holder shall execute a separate letter confirming his or her agreement to comply with this Section.

(f) Adjustments for Changes in Capital Structure. If, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in the Common Stock, the outstanding Shares are increased or decreased or are exchanged for a different number or kind of securities of the Company, the restrictions contained in this Section 9 shall apply with equal force to additional and/or substitute securities, if any, received by Holder in exchange for, or by virtue of his or her ownership of, Shares.

(g) Termination. The terms and provisions of Section 9(b) and Section 9(c) (except for the Company’s right to repurchase Shares still subject to a risk of forfeiture upon a Termination Event) shall terminate upon consummation of any Sale Event, in either case as a result of which Shares are registered under Section 12 of the Exchange Act and publicly-traded on any national security exchange.

SECTION 11. TAX WITHHOLDING

(a) Payment by Grantee. Each grantee shall, no later than the date as of which the value of an Award or of any Shares or other amounts received thereunder first becomes includable in the gross income of the grantee for income tax purposes, pay to the Company, or make arrangements satisfactory to the Committee regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by the Company with respect to such income. The Company and any Subsidiary shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company’s obligation to deliver stock certificates (or evidence of book entry) to any grantee is subject to and conditioned on any such tax withholding obligations being satisfied by the grantee.

Annex A-12

Table of Contents

(b) Payment in Stock. The Company’s minimum required tax withholding obligation may be satisfied, in whole or in part, by the Company withholding from Shares to be issued pursuant to an Award a number of Shares having an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the minimum withholding amount due.

SECTION 12. SECTION 409A AWARDS

To the extent that any Award is determined to constitute “nonqualified deferred compensation” within the meaning of Section 409A (a “409A Award”), the Award shall be subject to such additional rules and requirements as may be specified by the Committee from time to time. In this regard, if any amount under a 409A Award is payable upon a “separation from service” (within the meaning of Section 409A) to a grantee who is considered a “specified employee” (within the meaning of Section 409A), then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after the grantee’s separation from service, or (ii) the grantee’s death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties and/or additional tax imposed pursuant to Section 409A. The Company makes no representation or warranty and shall have no liability to any grantee under the Plan or any other Person with respect to any penalties or taxes under Section 409A that are, or may be, imposed with respect to any Award. It is the intent of the Board that payments and benefits under the Plan comply with or be exempt from Section 409A and the regulations and guidance promulgated thereunder and, accordingly, to the maximum extent permitted the Plan shall be interpreted to be in compliance therewith or exempt therefrom. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed upon a Participant by Section 409A or damages to a Participant for failing to comply with Section 409A

SECTION 13. AMENDMENTS AND TERMINATION

The Board may, at any time, amend or discontinue the Plan and the Committee may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall adversely affect rights under any outstanding Award without the consent of the holder of the Award. The Committee may exercise its discretion to reduce the exercise price of outstanding Stock Options or effect repricing through cancellation of outstanding Stock Options and by granting such holders new Awards in replacement of the cancelled Stock Options. To the extent determined by the Committee to be required either by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section 422 of the Code or otherwise, Plan amendments shall be subject to approval by the Company stockholders entitled to vote at a meeting of stockholders. Nothing in this Section 12 shall limit the Board’s or Committee’s authority to take any action permitted pursuant to Section 3(c). The Board reserves the right to amend the Plan and/or the terms of any outstanding Stock Options to the extent reasonably necessary to comply with the requirements of the exemption pursuant to paragraph (0(4) of Rule 12h-1 of the Exchange Act.

SECTION 14. STATUS OF PLAN

With respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Committee shall otherwise expressly so determine in connection with any Award.

SECTION 15. GENERAL PROVISIONS

(a) No Distribution; Compliance with Legal Requirements. The Committee may require each person acquiring Shares pursuant to an Award to represent to and agree with the Company in writing that such person is acquiring the Shares without a view to distribution thereof. No Shares shall be issued pursuant to an Award until all applicable securities law and other legal and stock exchange or similar requirements have been satisfied. The Committee may require the placing of such stop-orders and restrictive legends on certificates for Stock and Awards, as it deems appropriate.

(b) Delivery of Stock Certificates. Stock certificates to grantees under the Plan shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at the grantee’s last known address on file with the Company; provided that stock certificates to be held in escrow pursuant to Section 9 of the Plan shall be deemed delivered when the Company shall have recorded the issuance in its records. Uncertificated Stock shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have given to the grantee by electronic

Annex A-13

Table of Contents

mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee’s last known address on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic “book entry” records).

(c) No Employment Rights. The adoption of the Plan and the grant of Awards do not confer upon any Person any right to continued employment or Service Relationship with the Company or any Subsidiary.

(d) Trading Policy Restrictions. Option exercises and other Awards under the Plan shall be subject to the Company’s insider trading policy-related restrictions, terms and conditions as may be established by the Committee, or in accordance with policies set by the Committee, from time to time.

(e) Designation of Beneficiary. Each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise any Award on or after the grantee’s death or receive any payment under any Award payable on or after the grantee’s death. Any such designation shall be on a form provided for that purpose by the Committee and shall not be effective until received by the Committee. If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee’s estate.

(f) Legend. Any certificate(s) representing the Shares shall carry substantially the following legend (and with respect to uncertificated Stock, the book entries evidencing such shares shall contain the following notation):

The transferability of this certificate and the shares of stock represented hereby are subject to the restrictions, terms and conditions (including repurchase and restrictions against transfers contained in the Plan and any agreements entered into thereunder by and between the company and the holder of this certificate (a copy of which is available at the offices of the company for examination).

(g) Information to Holders of Options. In the event the Company is relying on the exemption from the registration requirements of Section 12(g) of the Exchange Act contained in paragraph (f)(1) of Rule 12h-1 of the Exchange Act, the Company shall provide the information described in Rule 701(e)(3), (4) and (5) of the Securities Act to all holders of Options in accordance with the requirements thereunder. The foregoing notwithstanding, the Company shall not be required to provide such information unless the option holder has agreed in writing, on a form prescribed by the Company, to keep such information confidential.

SECTION 16. EFFECTIVE DATE OF PLAN

The Plan shall become effective upon adoption by the Board and shall be approved by stockholders in accordance with applicable state law and the Company’s articles of incorporation and bylaws within 12 months thereafter. If the stockholders fail to approve the Plan within 12 months after its adoption by the Board of Directors, then any Awards granted or sold under the Plan shall be rescinded and no additional grants or sales shall thereafter be made under the Plan. Subject to such approval by stockholders and to the requirement that no Shares may be issued hereunder prior to such approval, Stock Options and other Awards may be granted hereunder on and after adoption of the Plan by the Board. No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the date the Plan is adopted by the Board or the date the Plan is approved by the Company’s stockholders, whichever is earlier.

SECTION 17. GOVERNING LAW

This Plan, all Awards and any controversy arising out of or relating to this Plan and all Awards shall be governed by and construed in accordance with the laws of the State of Delaware as to matters within the scope thereof, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.

DATE ADOPTED BY THE BOARD OF DIRECTORS: February 19, 2019.

DATE ADOPTED BY THE SHAREHOLDERS: August 29, 2019.

Annex A-14

Table of Contents

1 1 NAME THE COMPANY NAME INC. - COMMON 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS A 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS B 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS C 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS D 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS E 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS F 123,456,789,012.12345 THE COMPANY NAME INC. - 401 K 123,456,789,012.12345 x 02 0000000000 JOB # 1 OF 2 1 OF 2 PAGE SHARES CUSIP # SEQUENCE # THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date CONTROL # SHARES To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000520169_1 R1.0.0.177 For Withhold For All All All Except The Board of Directors recommends you vote FOR the following: 1. Election of Directors Nominees 01) Robert Liscouski 02) Robert Fagenson 03) Christopher Roberts 04) William J. McGann 05) Bertrand Velge QUANTUM COMPUTING INC. 215 DEPOT COURT SE, SUITE 215 LEESBURG, VA 20175 Investor Address Line 1 Investor Address Line 2 Investor Address Line 3 Investor Address Line 4 Investor Address Line 5 John Sample 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1 Investor Address Line 1 Investor Address Line 2 Investor Address Line 3 Investor Address Line 4 Investor Address Line 5 John Sample 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1SCAN TO VIEW MATERIALS & VOTE VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. ET on 10/26/2021.11/06/2023. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-maile-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY PHONE - 1-800-690-69031-800-690-6903 Use any touch-tonetouch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. ET on 10/26/2021.11/06/2023. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paidpostage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY For All Withhold All For All Except To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below. The Board of Directors recommends you vote FOR proposals 2 and 3. For Against Abstain 2. To approve an amendment to the Company’s 2019 Equity and Incentive Plan to increase the maximum number of shares available from 1,500,000 3,000,000. 3. To approve, on a non-binding basis, the compensation of the Company’s executive officers. The Boardfollowing: 1. Election of Directors recommends you vote 1 YEAR on the following proposal: 1 year 2 years 3 years Abstain 4. To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company’s executive officers.Nominees 01) Robert Liscouski 02) Robert Fagenson 03) Michael Turmelle 04) Bertrand Velge 05) Yuping Huang 06) Carl Weimer The Board of Directors recommends you vote FOR the following proposal: For Against Abstain 5.proposals: 2. To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in this Proxy Statement. 3. To ratify the selection of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December31, 2021.2023. NOTE: To transact such other business as may properly come before the meeting. For Against Abstain Please indicate if you plan to attend this meeting Yes No Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Yes No Please indicate if you plan to attend this meetingSignature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date

 

Table of Contents

0000520169_2 R1.0.0.177 Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form 10-K10-K are available at www.proxyvote.com QUANTUM COMPUTING INC. Annual Meeting of Shareholders To be held on Tuesday, November12, 2021 10:00 AM 7, 2023 This proxy is solicited by the Board of Directors The shareholder(s) hereby appoint(s) Robert Liscouski as proxy, with the power to appoint his substitute, and hereby authorizeauthorize(s) him to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common stock of QUANTUM COMPUTING INC. that the shareholder(s) is/are entitled to vote at the Annual Meeting of Shareholders to be held at 10:00 AM, EDT on November12, 2021, 7, 2023, at 215 Depot Court SE, Leesburg, VA 20175, and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors’ recommendations. Continued and to be signed on reverse side

 

Table of Contents

Your Vote Counts! Get informed before you vote View the Notice of Proxy Statement, Annual Report,1234567890123456789012345678901234567890, 123456789012345678 9012345678901234567890, 1234567890123456789012345678901234567890, 12345678901234567890123456789012345 67890 online OR you can receive a free paper copy of voting material(s) by requesting prior to <matcutoff>. If you would like to request a copy of the voting material(s), you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # FLASHID-JOB# Ricky Campana P.O. Box 123456 Suite 500 51 Mercedes Way Edgewood, NY 11717 1 OF 2 322,224 148,294 30# XXXX XXXX XXXX XXXX QUANTUM COMPUTING INC. 2021 Annual Meeting Vote by November11, 2021 11:59 PM                           ET QUANTUM COMPUTING INC. 215 DEPOT COURT SE, SUITE 215 LEESBURG, VA 20175 You invested in QUANTUM COMPUTING INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on November12, 2021. & Proxy Statement, Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to October13, 2021. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote in Person at the Meeting* November12, 2021 10:00 AM EDT 215 Depot Court SE Leesburg, VA 20175 *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

Table of Contents

THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”. Voting Items Board Recommends FLASHID-JOB# Control # XXXX XXXX XXXX XXXX THE COMPANY NAME INC. - COMMON ASDFGHJKL 123456789.1234 THE COMPANY NAME INC. - CLASS A 123456789.1234 THE COMPANY NAME INC. - CLASS B 123456789.1234 THE COMPANY NAME INC. - CLASS C 123456789.1234 THE COMPANY NAME INC. - CLASS D 123456789.1234 THE COMPANY NAME INC. - CLASS E 123456789.1234 THE COMPANY NAME INC. - CLASS F 123456789.1234 THE COMPANY NAME INC. - 401 K 123456789.1234 SHARE CLASSES REPRESENTED FOR VOTING upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of Directors Nominees: 01) Robert Liscouski 03) Christopher Roberts 05) Bertrand Velge 02) Robert Fagenson 04) William J. McGann For 2. To approve an amendment to the Company’s 2019 Equity and Incentive Plan to increase the maximum number of shares available from 1,500,000 to 3,000,000. For 3. To approve, on a non-binding basis, the compensation of the Company’s executive officers. For 4. To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company’s executive officers. Year 5. To ratify the selection of BF Borgers CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December31, 2021. For NOTE: To transact such other business as may properly come before the meeting.